As filed with the U.S. Securities and Exchange
Commission on August 11, 2023
Registration No. 333-272954
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 1
TO FORM F-3
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
Kaixin Auto Holdings
(Exact name of registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s name into English)
Cayman Islands |
|
Not Applicable |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
9/F, Tower A, Dongjin International Center
Huagong Road
Chaoyang District, Beijing 100015
People’s Republic of China
+86 010-6720-4948
(Address and telephone number of Registrant’s
principal executive offices)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, New York 10016
+1 (212) 947-7200
(Name, address, and telephone number of agent for
service)
With a copy to:
Yu Wang, Esq.
King & Wood Mallesons
13/F Gloucester Tower
The Landmark
15 Queen's Road Central
Central, Hong Kong
+852 3443 1150
Approximate date of commencement of proposed sale
to the public: From time to time after the effective date of the registration statement.
If
only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check
the following box. ¨
If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
box. x
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. ¨
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box
and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
If
this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become
effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ¨
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register
additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following
box. ¨
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging
growth company ¨
If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided
pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
† |
The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. |
The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the
Securities Act, or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section 8(a), may determine.
Pursuant to the provisions of Rule 429
under the Securities Act, the prospectus contained in this registration statement also relates to the Company’s registration statements
on Form F-3 (File No. 333-258450). Upon effectiveness, this registration statement will also act as a post-effective amendment
to such earlier registration statements.
EXPLANATORY
NOTE
The registrant is filing
a single prospectus in this registration statement pursuant to Rule 429 under the Securities Act of 1933, as amended (the “Securities
Act”). Pursuant to Rule 429 under the Securities Act, the prospectus included herein is a combined prospectus which relates
to:
| (i) | the offering and sale of up to an aggregate of US$80,000,000 of, together or separately, our ordinary
shares with a par value of US$0.00005 per share (“Ordinary Shares”), preferred shares, debt securities, warrants, rights,
and units, or any combination, which are currently registered and remain unsold under the Company’s registration statement on Form F-3
(File No. 333-258450) with the U.S. Securities and Exchange Commission (the “SEC”), which was subsequently declared effective
by the SEC on February 16, 2023 (the “Prior Registration Statement”); |
| (ii) | the offering and sale from time to time by the selling securityholders identified below of up to 52,562,303
Ordinary Shares (including 7,138,863 Ordinary Shares issuable upon the exercise of Warrants) and up to 7,138,863 Warrants to purchase
7,138,863 Ordinary Shares, which are currently registered and remain unsold under the Prior Registration Statement; |
| (iii) | the offering and sale of up to an additional US$220,000,000 of, together or separately, Ordinary Shares,
preferred shares, debt securities, warrants, rights, and units, or any combination thereof in this registration statement; |
| (iv) | the offering and sale from time to time by the selling securityholders identified below of up to 97,007,661
Ordinary Shares in this registration statement (including 50,000,000 Ordinary Shares issuable upon the conversion of 50,000 convertible
Series F Preferred Shares). |
Pursuant to Rule 429
under the Securities Act, this registration statement, which is a new registration statement, also constitutes a post-effective amendment
to the Prior Registration Statement, and such post-effective amendment shall hereafter become effective concurrently with the effectiveness
of this registration statement in accordance with Section 8(c) of the Securities Act.
The information in this prospectus
is not complete and may be changed. We may not sell the securities until the registration statement filed with the U.S. Securities and
Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting any offer to buy these
securities in any jurisdiction where such offer or sale is not permitted.
SUBJECT TO COMPLETION |
DATED
AUGUST 11, 2023 |
PROSPECTUS
Up to US$300,000,000 of
Ordinary Shares
Preferred Shares
Debt Securities
Warrants
Rights
Units
and
Up to 149,569,964 Ordinary Shares (including
7,138,863 Ordinary Shares issuable upon the exercise of Warrants and 50,000,000 Ordinary Shares issuable upon the conversion of 50,000
convertible Series F Preferred Shares) and up to 7,138,863 Warrants to purchase 7,138,863 Ordinary Shares offered by the selling securityholders
Kaixin Auto Holdings
We may, from time to time, in one or more offerings,
offer and sell of up to US$300,000,000, together or separately, of our Ordinary Shares, preferred shares, debt securities, warrants, rights,
and units, or any combination thereof as described in this prospectus. In this prospectus, references to the term “securities”
refers collectively to our Ordinary Shares, preferred shares, debt securities, warrants, rights, and units. The offer and sale of up to
US$80,000,000 of our Ordinary Shares was previously registered pursuant to our registration on Form F-3 (File No. 333-258450),
which we filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 2, 2023, and was declared effective
by the SEC on February 16, 2023 (the “Prior Registration Statement”). Pursuant to Rule 429 under the Securities
Act of 1933, as amended (the “Securities Act”), this prospectus updates the Prior Registration Statement and includes the
Ordinary Shares previously registered by us pursuant to such Prior Registration Statement.
In addition, selling securityholders named in
this prospectus or their transferees may, from time to time in one or more offerings, offer and sell of up to 149,569,964 of our Ordinary
Shares (including 7,138,863 Ordinary Shares issuable upon the exercise of warrants and 50,000,000 Ordinary Shares issuable upon the conversion
of 50,000 convertible Series F Preferred Shares) and up to 7,138,863 warrants to purchase 7,138,863 of our Ordinary Shares. We will not
receive any proceeds from the sale of our securities by our selling securityholders, but we may pay certain registration and offering
fees and expenses associated with the registration and sale of those securities. See “Selling Securityholders.”
Our Holding Company Structure
We are not an operating company in China, but
a Cayman Islands holding company. We conduct our operations in China through our PRC subsidiaries. Investors of our ordinary shares are
not purchasing equity interest in our operating entities in China but instead are purchasing equity interest in a Cayman Islands holding
company.
We face various legal and operational risks and
uncertainties associated with being based in or having our operations primarily in China and the complex and evolving PRC laws and regulations.
For instance, we face risks associated with regulatory approvals on offerings conducted overseas by and foreign investment in China-based
issuers, anti-monopoly regulatory actions, and oversight on cybersecurity and data privacy. These risks could result in a material adverse
change in our operations and the value of our ordinary shares, significantly limit or completely hinder our ability to offer or continue
to offer securities to investors, or cause the value of such securities to significantly decline. For a detailed description of risks
related to doing business in China, see “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business
in China” on page 34 to 54 of our most recent annual report on Form 20-F.
PRC government’s significant authority in
regulating our operations and its oversight and control over offerings conducted overseas by, and foreign investment in, China-based issuers
could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. Implementation of industry-wide
regulations in this nature may cause the value of such securities to significantly decline or be of little or no value. For more details,
see “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business in China — The Chinese government
exerts substantial influence over the manner in which we must conduct our business activities. We are currently not required to obtain
approval from Chinese authorities to issue securities to foreign investors, however, if our subsidiaries or the holding company were required
to obtain approval in the future and were denied permission from Chinese authorities to list on U.S. exchanges, we will not be able to
continue listing on U.S. exchange, which would materially affect the interest of the investors.” included in our most recent annual
report on Form 20-F.
As of the date of this prospectus, our Company
and the subsidiaries have not been involved in any investigations or review initiated by any PRC regulatory authority, not has any of
them received any inquiry, notice or sanction for the business operation, accepting foreign investment or listing on the Nasdaq Stock
Market. However, since these statements and regulatory actions by China’s government are newly published, official guidance and
related implementation rules have not been issued. It is highly uncertain what future impact such modified or new laws and regulations
will have on our daily business operations, the ability to accept foreign investments and our continued listing on the Nasdaq Stock Market.
There are also substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations and
rules regarding the status of the rights of us with respect to our assets and business operations in China. If we are found to be
in violation of any existing or future PRC laws or regulations, or fail to obtain or maintain any of the required permits or approvals,
the relevant PRC regulatory authorities would have broad discretion to take action in dealing with such violations or failures. See “Item
3. Key Information — D. Risk Factors — Risks Related to Our Corporate Structure — Substantial uncertainties exist with
respect to the interpretation and implementation of the PRC Foreign Investment Law, and it may materially and adversely affect the viability
of our current corporate structure, corporate governance and business operations.” on page 33 of our most recent annual report
on Form 20-F.
Our
subsidiaries are subject to certain legal and operational risks associated with being based in China. PRC laws and regulations
governing the subsidiaries’ current business operations are sometimes vague and uncertain, and as a result these risks may
result in material change in the operations of our subsidiaries, significant depreciation of the value of our ordinary shares, a
complete hindrance of our ability to offer or continue to offer our securities to investors, or cause the value of such securities
to significantly decline or be worthless. See “Item 3. Key Information - D. Risk Factors - Risks Related to Doing Business in
China - Uncertainties with respect to the PRC legal system could adversely affect us.” on page 40 of our most recent
annual report on Form 20-F. In the past few years, PRC government adopted a series of regulatory actions and issued statements
to regulate business operations in China, including those related to data security, and anti-monopoly concerns. For example, On
June 10, 2021, the Standing Committee of the National People’s Congress of China (the “SCNPC”), promulgated
the PRC Data Security Law, which took effect in September 2021. The PRC Data Security Law imposes data security and privacy
obligations on entities and individuals carrying out data activities, and introduces a data classification and hierarchical
protection system based on the importance of data in economic and social development, and the degree of harm it will cause to
national security, public interests, or legitimate rights and interests of individuals or organizations when such data is tampered
with, destroyed, leaked, illegally acquired or used. The PRC Data Security Law also provides for a national security review
procedure for data activities that may affect national security and imposes export restrictions on certain data an information.
Moreover, the Anti-monopoly Law promulgated by the SCNPC requires that transactions which are deemed concentrations and
involve parties with specified turnover thresholds must be cleared by the anti-monopoly enforcement agency before they can be
completed. Furthermore, the Measures for the Security Review of Foreign Investment promulgated by the NDRC and the Ministry of
Commerce in December 2020 specify that foreign investments in military, national defense-related areas or in locations in
proximity to military facilities, or foreign investments that would result in acquiring the actual control of assets in certain key
sectors, such as critical agricultural products, energy and resources, equipment manufacturing, infrastructure, transport, cultural
products and services, information technology, Internet products and services, financial services and technology sectors, are
required to obtain approval from designated governmental authorities in advance.
Our subsidiaries that operate online platforms
in the PRC will be recognized as online platform operators. Therefore, the Revised Measures of Cybersecurity Review shall apply to such
online platform operators. As of the date of this prospectus, for an “online platform operator” that is in possession of personal
data of more than one million users intends to list in a foreign country, it must apply for a cybersecurity review. See “Item 3.
Key Information - D. Risk Factors - Risks Related to Doing Business in China - The Chinese government exerts substantial influence over
the manner in which we must conduct our business activities. We are required to file with the CSRC within 3 working days after the subsequent
securities offering is completed and we might face warnings or fines if we fail to fulfill related filing procedure. We may become subject
to more stringent requirements with respect to matters including cross-border investigation and enforcement of legal claims.” on
page 34 to 37 of our most recent annual report on Form 20-F.
Termination of VIE Agreements and Disposition
of VIEs
Historically, as a Cayman Islands holding company,
we conduct our operations in China through our PRC subsidiaries and the VIEs. We had relied on contractual arrangements among our PRC
subsidiaries, the VIEs and their shareholders to receive economic benefits from the business operations of the VIEs in PRC in which we
have no equity ownership. Our corporate structure was subject to risks associated with our contractual arrangements with the VIEs. Investors
may never directly hold equity interests in the VIEs. If the PRC government finds that the agreements that establish the structure for
operating our business do not comply with the PRC laws and regulations, or if these regulations or their interpretations change in the
future, we could be subject to severe penalties or be forced to relinquish our interests in those operations. Our holding company, our
PRC subsidiaries, the VIEs, and investors of our Company face uncertainty about potential future actions by the PRC government that could
affect the enforceability of the contractual arrangements with the VIEs and, consequently, significantly affect the financial performance
of the VIEs and our Company as a whole. In addition, the company had a large number of inactive shell companies, which were the result
of its historical legacy and no longer relevant for its car sale businesses. Those inactive entities and the VIEs simply caused extra
maintenance costs, regulatory risk, and disclosure burdens. To streamline its corporate structure, mitigate the uncertainties, and exert
full control of our operating entities, we transferred operations in the VIEs to our wholly-owned entities and disposed of Renren Finance, Inc.,
which was our wholly-owned subsidiary that contractually controls the VIEs.
On August 5, 2022, KAG, our wholly-owned
subsidiary, and Stanley Star Group Inc (“Stanley Star”) entered into a shares transfer agreement (the “August 2022
Agreement”). The Agreement stipulates that KAG agrees to sell all the shares it held in Renren Finance, Inc. along with its
subsidiaries and VIEs and the VIEs’ subsidiaries (collectively referred to as the “Disposal Group”) at a consideration
of $1 to Stanley Star, an independent third party company incorporated in British Virgin Islands (“BVI”) that was interested
in exploring the opportunities in the non-performing assets on the books of the Disposal Group. In addition, the August 2022 Agreement
stipulates that on the date of the Disposal Completion Date if the net liabilities of the Disposal Group exceeded RMB20 million, the Company
shall make compensation to Stanley Star accordingly.
The sale of the Disposal Group and the ownership
transfer were completed on October 27, 2022 (the “Disposal Completion Date”), on which date the net book value of the
Disposal Group recorded net liabilities which was approximately $24.6 million. On December 28, 2022, KAG and Stanley Star entered
into a supplemental agreement pursuant to which the Company agrees to compensate Stanley Star pursuant to the August 2022 Agreement.
On March 24, 2023, KAG and Stanley Star entered into an amendment to the supplemental agreement, a securities purchase agreement
(the “Series F Agreement”), pursuant to which the Company agrees to issue Stanley Star an aggregate of 50,000 Series F
Convertible Preferred Shares (the “Series F Preferred Shares”), each of which is convertible into 1,000 ordinary shares
of the Company. The issuance of Series F Preferred Shares was closed in May 2023 upon the relevant approval from the competent
authorities of the Company under the laws of Cayman Islands.
In addition, we terminated all contractual arrangements
with Haitaoche VIEs in June and August 2022.
With the disposition of the Disposal Group and
Haitaoche VIEs, all VIEs were disposed as of October 27, 2022 (“Disposal of Subsidiaries”, see Note 4 of our consolidated
financial statement for the fiscal year ended December 31, 2022) and “Item 4. Information on the Company - C. Organizational
Structure.” on page from 83 to 87 of our most recent annual report on Form 20-F. As a result, there is no VIE entity in
the corporate structure of the Company and as of the date of this prospectus, we conduct our operations exclusively through our wholly-owned
subsidiaries.
Permissions Required from the PRC Authorities
for Our Operations
We
conduct our business through our subsidiaries in China. Our operations in China are governed by PRC laws and regulations. As of the date
of this prospectus, our Company and our subsidiaries have not been involved in any investigations or review initiated by any PRC regulatory
authority, not has any of them received any inquiry, notice or sanction for our operations or our issuance of securities to investors.
Nevertheless, the SCNPC or PRC regulatory authorities may in the future promulgate laws, regulations or implementing rules that
requires us and our subsidiaries to obtain permissions from PRC regulatory authorities to conduct business operations in China.
In addition, as of the date of this prospectus,
except for business license, foreign investment information report to the commerce administrative authority and foreign exchange registration
or filing, our consolidated affiliated Chinese entities do not have to obtain any requisite licenses and permits from the PRC government
authorities that are material for the business operations of our holding company and our subsidiaries in China. However, given the uncertainties
of interpretation and implementation of relevant laws and regulations and the enforcement practice by government authorities, we may be
required to obtain certain licenses, permits, filings or approvals for the functions and services that we provided in the future.
The Holding Foreign Companies Accountable Act
In addition, our Ordinary Shares may be prohibited
from trading on a national exchange or over-the-counter under the Holding Foreign Companies Accountable Act (“HFCA Act”)
if the Public Company Accounting Oversight Board (United States) (the “PCAOB”) is unable to inspect our auditor for three
consecutive years. Our current auditor, Onestop Assurance PAC (“Onestop”), and our prior auditor for the 2020 and 2021 annual
reports, Marcum Asia CPAs LLP (Formerly known as Marcum Bernstein & Pinchuk LLP), or Marcum Asia, the independent registered public
accounting firms that issued our financial reports incorporated by reference in this prospectus or included in our most recent annual
report on Form 20-F, are registered with the PCAOB. The PCAOB conducts regular inspections to assess their compliance with the applicable
professional standards. Onestop and Marcum Asia are headquartered in Singapore and New York, respectively. On December 16, 2021, the
PCAOB issued a report notifying the SEC of its determinations (the “PCAOB Determinations”) that they are unable to inspect
or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong. The report sets forth
lists identifying the registered public accounting firms headquartered in mainland China and Hong Kong, respectively, that the PCAOB
is unable to inspect or investigate completely, and as of the date of this prospectus, Onestop and Marcum Asia are not included in the
list of PCAOB Identified Firms in the PCAOB Determinations issued on December 16, 2021. On August 26, 2022, the China Securities Regulatory
Commission (the “CSRC”), the Ministry of Finance of the PRC (the “MOF”), and the PCAOB signed a Statement of
Protocol (the “Protocol”), governing inspections and investigations of audit firms based in China and Hong Kong. Pursuant
to the Protocol, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the
unfettered ability to transfer information to the U.S. Securities and Exchange Commission. On December 15, 2022, the PCAOB announced
that it was able to secure complete access to inspect and investigate completely registered public accounting firms headquartered in
mainland China and Hong Kong and voted to vacate its previous determinations issued in December 2021. As such, we do not expect to be
identified as a “Commission-Identified Issuer” under the HFCA Act for the fiscal year ended December 31, 2022. Notwithstanding
the foregoing, in the event it is later determined that the PCAOB is unable to inspect or investigate completely our auditor, then such
lack of inspection could cause our securities to be delisted from Nasdaq Stock Market. In addition, whether the PCAOB will continue be
able to conduct inspections and investigations completely to its satisfaction of PCAOB-registered public accounting firms headquartered
in mainland China and Hong Kong is subject to uncertainty and depends on a number of factors out of our, and our auditor’s, control,
including positions taken by authorities of the PRC. The PCAOB is expected to continue to demand complete access to inspections and investigations
against accounting firms headquartered in mainland China and Hong Kong in the future and states that it has already made plans to resume
regular inspections in early 2023 and beyond. The PCAOB is required under the HFCA Act to make its determination on an annual basis with
regards to its ability to inspect and investigate completely accounting firms based in the mainland China and Hong Kong. The possibility
of being a “Commission-Identified Issuer” and risk of delisting could continue to adversely affect the trading price of our
securities. Should the PCAOB again encounter impediments to inspections and investigations in mainland China or Hong Kong as a result
of positions taken by any authority in either jurisdiction, the PCAOB will make determinations under the HFCA Act as and when appropriate.
On December 29, 2022, the Accelerating Holding Foreign Companies Accountable Act was enacted, which amended the Holding Foreign Companies
Accountable Act, by requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor
is not subject to PCAOB inspections for two consecutive years instead of three. See “Risk Factors—Risks Related to Doing
Business in China—If the PCAOB is unable to inspect our auditors as required under the Holding Foreign Companies Accountable Act,
the SEC will prohibit the trading of our shares. A trading prohibition for our shares, or the threat of a trading prohibition, may materially
and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections of our auditors, if
any, would deprive our investors of the benefits of such inspections.” of this prospectus.
Cash and Asset Flows through Our Organization
We transfer cash to our wholly-owned Hong Kong
subsidiaries, by making capital contributions or providing loans, and the Hong Kong subsidiaries transfer cash to the subsidiaries in
China by making capital contributions or providing loans to them. See “Item 18—Financial
Statements” on page 138 of our most recent annual report on Form 20-F. No
dividends or distributions have been declared to pay to the Company from our subsidiaries. No dividends or distributions were made by
the Company to any U.S. investors. The Company does not have any present plan to pay any cash dividends on its ordinary shares in the
foreseeable future. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand
our business.
Under PRC laws and regulations, our PRC subsidiaries
are subject to certain restrictions with respect to paying dividends or otherwise transferring any of their net assets to us. Remittance
of dividends by a wholly foreign-owned enterprise out of China is also subject to examination by the banks designated by SAFE. The majority
of the Company’s and our PRC subsidiaries’ income is received in RMB and shortages in foreign currencies may restrict our
ability to pay dividends or other payments, or otherwise satisfy our foreign currency denominated obligations, if any. Under existing
PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and expenditures
from trade-related transactions, can be made in foreign currencies without prior approval from SAFE as long as certain procedural requirements
are met. Approval from appropriate government authorities is required if RMB is converted into foreign currency and remitted out of China
to pay capital expenses such as the repayment of loans denominated in foreign currencies. The Chinese government may, at its discretion,
impose restrictions on access to foreign currencies for current account transactions and if this occurs in the future, we may not be able
to pay dividends in foreign currencies to our shareholders. See “Summary of Risk Factors — Risks Related to Doing Business
in China — We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing
requirements that we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material
and adverse effect on our ability to conduct our business.” of this prospectus; and “Risk Factors — Risks Related to
Doing Business in China — We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash
and financing requirements that we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have
a material and adverse effect on our ability to conduct our business. Moreover, the Chinese government may, at its discretion, impose
restrictions on access to foreign currencies for current account transactions and if this occurs in the future, we may not be able to
pay dividends in foreign currencies to our shareholders.” of this prospectus; and “Item 3. Key Information — D. Risk
Factors — Risks Related to Doing Business in China — We may rely on dividends and other distributions on equity paid by our
PRC subsidiaries to fund any cash and financing requirements that we may have, and any limitation on the ability of our PRC subsidiaries
to make payments to us could have a material and adverse effect on our ability to conduct our business.” on page 41 of our
annual report on Form 20-F for the fiscal year ended December 31, 2022. The Company has not made any dividend payments in the
past and is not planning to make dividend payments in the near future in order to preserve capital to fund business growth. The amounts
restricted include the paid-up capital and the statutory reserve funds of our PRC subsidiaries and historically owned VIEs, totaling US$7.6
million, US$117.1 million and US$121.7 million as of December 31, 2020, 2021, and 2022, respectively. See “Dividend Distributions
and Cash Transfers within our Organization”.
Moreover, to the extent cash or assets in
the business are in the PRC/Hong Kong or a PRC/Hong Kong entity, the funds or assets may not be available to fund operations or for
other use outside of the PRC/Hong Kong due to interventions in or the imposition of restrictions and limitations on the ability of
the holding company or its subsidiaries by the PRC government to transfer cash or assets. See “Summary of Risk
Factors—Risks Related to Our Corporate Structure—Investing in our securities is highly speculative and involves a
significant degree of risk as we are a holding company incorporated in the Cayman Islands and historically operate our business
through VIE structure. To the extent cash or assets in the business are in the PRC/Hong Kong or a PRC/Hong Kong entity, funds or
assets may not be available to fund operations or for other use outside of the PRC/Hong Kong due to interventions in or the
imposition of restrictions and limitations on the ability of the holding company or its subsidiaries by the PRC government to
transfer cash or assets.” of this prospectus; and “Item 3. Key
Information—D. Risk Factors—Our
adjustment of corporate structure and business operations and the termination of contractual arrangement with the VIEs may not be
liability-free.” on page 32 of our most recent annual report on Form 20-F.
This prospectus provides a general description
of the securities we or the selling securityholders may offer. We will provide the specific terms of the securities offered in one or
more supplements to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with
these offerings. The prospectus supplement and any related free writing prospectus may add, update, or change information contained in
this prospectus. You should read carefully this prospectus, the applicable prospectus supplement, and any related free writing prospectus,
as well as the documents incorporated or deemed to be incorporated by reference, before you invest in any of our securities. This prospectus
may not be used to offer or sell any securities unless accompanied by the applicable prospectus supplement.
We may, from time to time, offer and sell these
securities and selling securityholders may, from time to time, offer the securities through public or private transactions, directly or
through one or more underwriters, dealers, brokers and agents, on or off the Nasdaq Capital Market, or Nasdaq, at prevailing market prices
or at privately negotiated prices. If any underwriters, dealers, brokers or agents are involved in the sale of any of these securities,
the applicable prospectus supplement will set forth the name of the underwriter, dealer, broker or agent and any applicable commissions
or discounts. The offering price of such securities and the net proceeds we expect to receive from such sale will also be set forth in
a prospectus supplement. See “Plan of Distribution” elsewhere in this prospectus for a more complete description of the ways
in which the securities may be sold.
Our Ordinary Shares are listed on Nasdaq under
the symbol “KXIN.” On June 26, 2023, the last reported sale price of the ordinary shares on Nasdaq was US$0.34 per ordinary
share.
We have experienced and may continue to experience price volatility
in our ordinary shares. See related risk factors in our most recent annual report on Form 20-F.
Investing in our securities involves risks.
See “Risk Factors” beginning on page 15 of this prospectus and risk factors set forth in our most recent annual
report on Form 20-F, in other reports incorporated herein by reference, and in an applicable prospectus supplement under the heading
“Risk Factors.”
Neither the U.S. Securities and Exchange Commission
nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2023
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of a registration
statement that we filed with the U.S. Securities and Exchange Commission (the “SEC”) utilizing a “shelf”
registration process. The term registration statement means the Prior Registration Statement and any and all amendments including
the schedules and exhibits to the Prior Registration Statement and this registration statement, which is combined with the Prior
Registration Statement pursuant to Rule 429 under the Securities Act. We may, from time to time, offer and sell, in one or more
offerings, up to US$300,000,000, together or separately, of our ordinary shares with a par value of US$0.00005 per share
(“Ordinary Shares”), preferred shares, debt securities, warrants, rights, and units, or any combination thereof as
described in this prospectus. In addition, selling securityholders named in Prior Registration Statement and this prospectus or
their transferees may, from time to time in one or more offerings, offer and sell up to 149,569,964 52,562,303 of our Ordinary
Shares (including 7,138,863 Ordinary Shares issuable upon the exercise of warrants and 50,000,000 Ordinary Shares issuable upon the
conversion of 50,000 convertible Series F Preferred Shares) and up to 7,138,863 warrants to purchase 7,138,863 of our Ordinary
Shares.
This prospectus provides you with a general description
of the securities we may offer. This prospectus and any accompanying prospectus supplement do not contain all of the information included
in the registration statement. We have omitted parts of the registration statement in accordance with the rules and regulations of
the SEC. Statements contained in this prospectus and any accompanying prospectus supplement about the provisions or contents of any agreement
or other documents are not necessarily complete. If the SEC rules and regulations require that an agreement or other document be
filed as an exhibit to the registration statement, please see that agreement or document for a complete description of these matters.
This prospectus may be supplemented by a prospectus supplement that may add, update, or change information contained or incorporated by
reference in this prospectus. You should read both this prospectus and any prospectus supplement or other offering materials together
with additional information described under the headings “Where You Can Find Additional Information” and “Incorporation
of Documents by Reference.”
Each time we sell securities under this shelf
registration, we will provide a prospectus supplement that will contain certain specific information about the terms of that offering,
including a description of any risks related to the offering. A prospectus supplement may also add, update, or change information contained
in this prospectus (including documents incorporated herein by reference). If there is any inconsistency between the information in this
prospectus and the applicable prospectus supplement, you should rely on the information in the prospectus supplement. The registration
statement we filed with the SEC includes exhibits that provide more details on the matters discussed in this prospectus. You should read
this prospectus and the related exhibits filed with the SEC and the accompanying prospectus supplement together with additional information
described under the headings “Incorporation of Documents by Reference” before investing in any of the securities offered.
You should rely only on the information provided
or incorporated by reference in this prospectus or in the prospectus supplement. Neither we nor the selling securityholders have authorized
anyone to provide you with additional or different information. Neither we nor the selling securityholders take responsibility for, nor
can we provide assurance as to the reliability of, any other information that others may provide. Neither we nor the selling securityholders
are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the
information in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the
date on the front of the document and that any information incorporated by reference is accurate only as of the date of the document incorporated
by reference, regardless of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing
prospectus, or any sale of a security, unless we indicate otherwise. Our business, financial condition, results of operations and/or prospects
may have changed since those dates.
As permitted by SEC rules and regulations,
the registration statement of which this prospectus forms a part includes additional information not contained in this prospectus. You
may read the registration statement and the other reports we file with the SEC at its website or at its offices described below under
“Where You Can Find Additional Information.”
COMMONLY USED DEFINED TERMS
Unless otherwise indicated or the context requires otherwise, references
in this prospectus or in a prospectus supplement to:
|
· |
“Business Combination” are to the transactions contemplated by the share exchange agreement dated as of November 2, 2018 by and among CM Seven Star Acquisition Corporation, KAG and Renren, pursuant to which we acquired 100% of the equity interests of KAG from Renren on April 30, 2019; |
|
· |
“China” or the “PRC” are to the People’s Republic of China, excluding, for the purposes of this prospectus only, Hong Kong, Macau and Taiwan; |
|
· |
“Dealerships” are to our dealership businesses operated by special purpose holding companies in which we possess majority ownership and voting control; |
|
· |
“Haitaoche” are to Haitaoche Limited; |
|
|
|
|
· |
“Haitaoche Acquisition” are to the transaction closed on June 25, 2021 in which Kaixin issued to shareholders of Haitaoche an aggregate of 74,035,502 ordinary shares of Kaixin in exchange of 100% share capital of Haitaoche; |
|
|
|
|
· |
“KAG” are to Kaixin Auto Group, our wholly-owned subsidiary acquired from Renren; |
|
· |
“Kaixin,” “we,” “us,” “the Company,” “our company” or “our” are to Kaixin Auto Holdings, our Cayman Islands holding company, and in the context of describing the combined and consolidated financial statements, also includes Kaixin’s subsidiaries and consolidated affiliated entities; |
|
· |
“Renren” are to Renren Inc., its subsidiaries its consolidated affiliated entities, and subsidiaries of its consolidated affiliated entities. The ADSs of Renren Inc. are listed on New York Stock Exchange under the symbol RENN; |
|
|
|
|
· |
“RMB” or “Renminbi” are to the legal currency of China; |
|
· |
“SaaS” are to “software-as-a-service”; |
|
· |
“US$,” “U.S. dollars,” “$,” or “dollars” are to the legal currency of the United States; |
|
· |
“U.S. GAAP” are to accounting principles generally accepted in the United States; and |
|
· |
“variable interest entities” or “VIEs” are to certain variable interest entities, including (i) Shanghai Qianxiang Changda Internet Information Technologies Development Co., Ltd., or Qianxiang Changda, and Zhejiang Jieying Auto Retail Co., Ltd., or Zhejiang Jieying, formerly known as Shanghai Jieying Auto Retail Co., Ltd., (together, the “Kaixin VIEs”, each a “Kaixin VIE”), and (ii) Qingdao Shengmeilianhe Import Automobile Sales Co., Ltd. (or “Qingdao Shengmei” or the “Haitaoche VIE”; and together with the Kaixin VIEs, the “VIEs”). The VIEs are 100% owned by PRC citizens and a PRC entity owned by PRC citizens, and are consolidated into our consolidated financial statements in accordance with U.S. GAAP as if they were our wholly-owned subsidiaries. |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, any applicable prospectus supplement,
and our SEC filings that are incorporated by reference into this prospectus may contain or incorporate by reference forward-looking statements
within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). Many of the forward-looking statements contained in this prospectus can be identified by the use of forward-looking
words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,”
“intend,” “estimate,” and “potential,” among others.
Forward-looking
statements appear in a number of places in this prospectus, an applicable prospectus supplement, and our SEC filings that are incorporated
by reference into this prospectus. These forward-looking statements include, but are not limited to, statements regarding our intent,
belief, or current expectations. Forward-looking statements are based on our management’s beliefs and assumptions and on information
currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially
from those expressed or implied in the forward-looking statements due to of various factors, including, but not limited to, those identified
under the section entitled “Item 3. Key Information—D. Risk Factors” in our annual report on Form 20-F for the fiscal year ended December 31, 2022. These risks and uncertainties include factors relating to:
|
· |
our goals and growth strategies; |
|
· |
our future business development, results of operations, and financial condition; |
|
· |
expected growth of the PRC automotive and related industries; |
|
· |
our expectations regarding the demand for, and market acceptance of, our products and services; |
|
· |
our expectations regarding our relationships with distributors, customers, suppliers, strategic partners and other stakeholders; |
|
· |
competition in our industry; |
|
· |
relevant government policies and regulations relating to our industry; |
|
· |
other factors that may affect our financial condition, liquidity, and results of operations; |
|
· |
other risk factors discussed under “Item 3. Key Information—D. Risk Factors” in our annual report on Form 20-F for the fiscal year ended December 31, 2022; and |
|
|
|
|
· |
assumptions underlying or related to any of the foregoing. |
Forward-looking statements speak only as of the
date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release
publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated
events. You are cautioned to consider these and any other factors that are discussed in the section entitled “Risk Factors”
elsewhere in this prospectus, in our most recent annual report on Form 20-F, and in any prospectus supplement or documents we incorporate
by reference into this prospectus. These risks are not exhaustive. These risks could cause actual results to differ materially from those
implied by forward-looking statements in this prospectus.
PROSPECTUS SUMMARY
Our Corporate Structure
We are a holding company incorporated in the Cayman
Islands and not a Chinese operating company. As a holding company with no material operations of our own, we conduct our operations through
our PRC subsidiaries in China.
The following diagram illustrates
our corporate structure, including our significant subsidiaries, as of the date of this prospectus:
![](https://www.sec.gov/Archives/edgar/data/1713539/000110465923090453/image_003.jpg)
As of the date of this prospectus, we have no VIEs in the PRC. Historically,
as a Cayman Islands holding company, we conduct our operations in China through our PRC subsidiaries and the VIEs. To mitigate the uncertainties
in our corporate structure and exert full control on our operating entities, we transferred operations in the VIEs to our wholly-owned
entities and disposed of Renren Finance, Inc., which was our wholly-owned subsidiary that contractually controls the VIEs. As such,
revenues contributed by the VIEs and their subsidiaries only accounted for 100% of our total revenues during the period from 2020 to the
Disposal Completion Date.
On August 5, 2022, KAG, our wholly-owned
subsidiary, and Stanley Star entered into the August 2022 Agreement, pursuant to which KAG agrees to sell all the shares it held
in Renren Finance, Inc. along with its subsidiaries and VIEs and the VIEs’ subsidiaries to Stanley Star, an independent third
party company incorporated in BVI, at a consideration of $1. In addition, the August 2022 Agreement stipulates that on the date of
the Disposal Completion Date, if the net liability of the Disposal Group exceeded RMB20 million, the Company shall make compensation to
Stanley Star accordingly.
The sale of Disposal Group and the ownership
transfer were completed on October 27, 2022, on which date the net book value of the Disposal Group recorded net liabilities
which was approximately $24.6 million. Accordingly, on December 28, 2022, KAG and Stanley Star entered into a supplemental
agreement pursuant to which the Company agrees to compensate Stanley Star pursuant to the August 2022 Agreement. On
March 24, 2023, KAG and Stanley Star entered into an amendment to the supplemental agreement, the Series F Agreement,
pursuant to which the Company agrees to issue Stanley Star an aggregate of 50,000 convertible Series F Preferred Shares, each
of which is convertible into 1,000 ordinary shares of the Company. The issuance of Series F Preferred Shares was closed in
May 2023 upon the relevant approval from the competent authorities of the Company under the laws of the Cayman Islands.
With the disposition of the Disposal Group,
all VIEs were disposed on October 27, 2022, See “Item 4. Information on the Company – A. History and Development of
the Company – Disposal of Renren Finance, Inc.” on page 57 in our most recent annual report on Form 20-F.
As a result, the contractual arrangements between our wholly-owned entities and the relevant VIEs were terminated, which includes
Loan Agreements, Equity Option Agreement, Power of Attorney, Business Operation Agreement, Equity Pledge Agreement, Exclusive
Technology Support and Technology Services Agreement, Intellectual Property Right License Agreement, Agreement on Disposal of
Equity and Assets, etc. For a detailed description of the relevant VIE agreements, see “Item 4. Information on the
Company – C. Organizational Structure – Contractual Agreements with the VIEs and Their Shareholders.” on
page 84 to 87 in our most recent annual report on Form 20-F. As of the date
of this prospectus, we conduct our operations exclusively through our wholly-owned subsidiaries.
We
are subject to certain legal and operational risks associated with being based in China and the complex and evolving PRC laws and
regulations. PRC laws and regulations governing our current business operations are sometimes vague and uncertain, and as a result these
risks may result in material change in the operations of our subsidiaries, significant depreciation of the value of our ordinary shares,
a complete hindrance of our ability to offer or continue to offer our securities to investors, or cause the value of such securities to
significantly decline or be worthless. Recently, the PRC government adopted a series of regulatory actions and issued statements to regulate
business operations in China, including those related to variable interest entities, data security, and anti-monopoly concerns. However,
since these statements and regulatory actions are newly published, official guidance and related implementation rules have not been
issued. It is highly uncertain what future impact such modified or new laws and regulations will have on our daily business operations,
the ability to accept foreign investments and our continued listing on the Nasdaq Stock Market. For
a detailed description of risks related to doing business in China, see “Item 3. Key Information — D. Risk Factors —
Risks Related to Doing Business in China” included in our most recent annual report on Form 20-F.
PRC
government’s significant authority in regulating our operations and its oversight and control over offerings conducted overseas
by, and foreign investment in, China-based issuers could significantly limit or completely hinder our ability to offer or continue to
offer securities to investors. Implementation of industry-wide regulations in this nature may cause the value of such securities to significantly
decline or be of little or no value. For more details, see “Item 3. Key Information — D. Risk Factors — Risks Related
to Doing Business in China — The Chinese government exerts substantial influence over the manner in which we must conduct our business
activities. We are required to file with the CSRC within 3 working days after the subsequent securities offering is completed and we might
face warnings or fines if we fail to fulfill related filing procedure. We may become subject to more stringent requirements with respect
to matters including cross-border investigation and enforcement of legal claims.” included in our most recent annual report on Form 20-F.
Moreover, the SCNPC or PRC regulatory authorities may in the future promulgate laws, regulations or implement rules that require
us or our subsidiaries to obtain permissions from PRC regulatory authorities to conduct our operations in China. If the CSRC or other
regulatory agencies later promulgate new rules or explanations requiring us to obtain their approvals for this offering, we may be
unable to obtain a waiver of such requirement. Further, the General Office of the Central Committee of the Communist Party of China and
the General Office of the State Council jointly issued the Opinions on Severe and Lawful Crackdown on Illegal Securities Activities, which
was available to the public on July 6, 2021. These opinions emphasized the need to strengthen the administration over illegal securities
activities and the supervision on overseas listings by China-based companies. These opinions proposed to take effective measures, such
as promoting the construction of relevant regulatory systems, to deal with the risks and incidents facing China-based overseas-listed
companies and the demand for cybersecurity and data privacy protection. Moreover, according to the Revised Measures of Cybersecurity Review
which was promulgated on December 28, 2021 and entered into force and effect and replaced the Measures for Cybersecurity Review on
February 15, 2022, a “online platform operator” that holds personal information of more than one million users shall
report to Cybersecurity Review Office for cybersecurity review when it seeks to list its securities overseas. Our subsidiaries that operate
online platforms in the PRC will be recognized as online platform operators. Therefore, the Revised Measures of Cybersecurity Review shall
apply to such online platform operators. As of the date of this prospectus, for entities that have been listed overseas before the implementation
of the Revised Measures of Cybersecurity Review and intend to issue additional shares rather than doing a public listing, the Revised
Measures of Cybersecurity Review do not clearly stipulate that such entities or their subsidiaries, as “online platform operators”,
shall report to Cybersecurity Review Office for cybersecurity review. Therefore, the Revised Measures of Cybersecurity Reviews remains
unclear on whether such requirements will be applicable to companies which are already listed in the United States, such as us. It also
remains uncertain whether any future regulatory changes would impose additional restrictions on companies like us. According
to Measures on Security Assessment of Outbound Data Transfer issued by Cyberspace Administration of China (“CAC”) on
July 7, 2022, which became effective on September 1, 2022 (“Measures on Outbound Data Transfer”), any data processor
that provides data overseas and meets the specific conditions shall apply to the national cyberspace administration authority for the
security assessment via the local provincial-level cyberspace administration authority. For any outbound data activity carried out before
September 1, 2022 which is not in compliance with the provisions of Measures on Outbound Data Transfer, rectification shall be completed
before March 1, 2023. The Measures on Outbound Data Transfer remains unclear on the consequences of failing to pass the security
assessment or the responsibility of failing to apply for the security assessment. We are
not able to guarantee that we will pass such security assessment nor the business operations will not be significantly affected if we
fail to pass such security assessment or fail to complete such rectification. The aforementioned policies and any related implementation
rules to be enacted may subject us to additional compliance requirement in the future. As these opinions were recently issued, official
guidance and interpretation of the opinions remain unclear in several respects at this time. Therefore, we cannot assure you that we will
remain fully compliant with all new regulatory requirements of these opinions or any future implementation rules on a timely basis,
or at all. We have been closely monitoring the development in the regulatory landscape in China, particularly regarding the requirement
of approvals, including on a retrospective basis, from the CSRC, the CAC or other PRC authorities, as well as regarding any annual data
security review or other procedures that may be imposed on us. If any approval, review or other procedure is in fact required, we may
not be able to guarantee that we will obtain such approval or complete such review or other procedure timely or at all. For any approval
that we may be able to obtain, it could nevertheless be revoked and the terms of its issuance may impose restrictions on our operations
and offerings relating to our securities.
Trading in our securities may be prohibited under the HFCA Act if
the PCAOB determines that it cannot inspect or fully investigate our auditor, and that as a result, an exchange may determine to
delist our securities. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act. On
December 23, 2022, the Accelerating Holding Foreign Companies Accountable Act was enacted, which amended the HFCA Act, by
requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to
PCAOB inspections for two consecutive years instead of three. In addition, on December 16, 2021, the PCAOB issued a report on
its determination that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in
China and in Hong Kong because of positions taken by PRC and Hong Kong authorities in those jurisdictions. On August 26, 2022,
the CSRC, the Ministry of Finance of the PRC (the “MOF”), and the PCAOB signed a Statement of Protocol (the
“Protocol”), governing inspections and investigations of audit firms based in China and Hong Kong. Pursuant to the
Protocol, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the
unfettered ability to transfer information to the U.S. Securities and Exchange Commission. On December 15, 2022, the PCAOB
announced that it was able to inspect and investigate completely registered public accounting firms headquartered in mainland China
and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise
fail to facilitate the PCAOB’s access in the future, the PCAOB Board will consider the need to issue a new determination.
Notwithstanding the foregoing, in the event it is later determined that the PCAOB is unable to inspect or investigate completely our
auditor, then such lack of inspection could cause our securities to be delisted from the Nasdaq Stock Market. Our current auditor,
Onestop, and our prior auditor for the 2020 and 2021 annual reports, Marcum Asia, the independent registered public accounting firms
that issue the financial reports included elsewhere in this prospectus or our most recent annual report on Form 20-F, are
registered with the PCAOB. The PCAOB conducts regular inspections to assess their compliance with the applicable professional
standards. Onestop and Marcum Asia are headquartered in Singapore and New York, respectively, and, as of the date of this
prospectus, they are not included in the list of PCAOB Identified Firms in the PCAOB Determinations issued on December 2021.
However, recent developments with respect to audits of China-based companies, such as us, create uncertainty about the ability of
our auditor to fully cooperate with the PCAOB’s request for audit workpapers without the approval of the Chinese authorities.
As a result, our investors may be deprived of the benefits of PCAOB’s oversight of our auditor through such inspections. See
“Item 3. Key Information—D. Risk Factors—Risks Related to Doing Business in China—If the PCAOB is unable to
inspect our auditors as required under the Holding Foreign Companies Accountable Act, the SEC will prohibit the trading of our
shares. A trading prohibition for our shares, or the threat of a trading prohibition, may materially and adversely affect the value
of your investment. Additionally, the inability of the PCAOB to conduct inspections of our auditors, if any, would deprive our
investors of the benefits of such inspections.” from page 48 to 49 of our annual report on Form 20-F for the fiscal
year ended December 31, 2022, filed with the SEC on May 16, 2023.
Moreover, to the extent cash or assets in the
business are in the PRC/Hong Kong or a PRC/Hong Kong entity, the funds or assets may not be available to fund operations or for other
use outside of the PRC/Hong Kong due to interventions in or the imposition of restrictions and limitations on the ability of the holding
company or its subsidiaries, by the PRC government to transfer cash or assets. See “Risk Factors— Investing in our securities
is highly speculative and involves a significant degree of risk as we are a holding company incorporated in the Cayman Islands and historically
operate our business through VIE structure. To the extent cash or assets in the business are in the PRC/Hong Kong or a PRC/Hong Kong entity,
funds or assets may not be available to fund operations or for other use outside of the PRC/Hong Kong due to interventions in or the imposition
of restrictions and limitations on the ability of the holding company or its subsidiaries by the PRC government to transfer cash or assets.”
of this prospectus.
Business Overview
As of the date of this prospectus, we conduct
our operations exclusively through our wholly-owned subsidiaries. The following description of our business is a description of the business
of our PRC subsidiaries.
Through our PRC subsidiaries, we are primarily
engaged in the sales of domestic and imported automobiles in the PRC. We are committed to providing
a superior car purchase and ownership experiences to customers.
We are a
leading premium used auto dealership group in China. As of December 31, 2022, we had three active used car Dealerships covering three
cities in China. On average, our Dealership operators have over ten years of experiences in the used car industry. We provide used car
buyers in China with access to a wide selection of used vehicles across our network of Dealerships, with a focus on premium brands, such
as Audi, BMW, Mercedes-Benz, Land Rover, Bentley, Rolls-Royce, and Porsche. In addition to auto sales, for the convenience of our customers,
we also provide financing channels to customers and other in-network dealers through partnerships with financial institutions.
China is the world’s largest automotive market both in demand
and supply in 2022. China’s used car market is characterized by the lack of brand differentiation and limited industry consolidation.
On June 25,
2021, we closed the Haitaoche Acquisition. Haitaoche is a China-based merchant for domestic and imported automobiles. The manufacture
and distribution of automobiles are undergoing significant changes in China, which are expected to create new opportunities and business
models. Haitaoche strives to become a leading automobile retail platform in China. In addition to maintaining its domestic and imported
new car sales business, it plans to expand into electronic vehicles and other business areas. Haitaoche aims to enter into strategic cooperation
agreements with multiple electronic vehicle manufacturers in China and serve a wider group of distributors and consumers.
By integrating
the operations and resources of Haitaoche with the used car dealership business, we are engaged in the sales of both new and used, domestic
and imported automobiles. We sourced, marketed and sold approximately 697, 1,814, and 879 vehicles to customers across China in 2020,
2021 and 2022, respectively.
We are actively
looking for opportunities to expand into the business area of electronic vehicles. We have set up the New Energy Vehicles Department in
2021 and delivered the new NEV prototype to our customer at the end of 2022. We released our new energy vehicle strategic plan on December 1,
2021, and we target to quickly expand our new energy vehicle team and start with developing commercial new energy vehicles for intra-city
and inter-city logistics applications in the initial stage.
In addition,
we have reached into a strategic partnership with Beijing Bujia Technology Co., Ltd. (“Bujia”) and obtained a sales order
for 5,000 new energy logistics vehicles with Bujia, a leading automobile logistics service provider in China. It will order a total of
RMB1 billion (equivalent to around US$156 million) worth of new energy vehicles from our Company in the next few years. The first model
vehicle was delivered to Bujia in July 2022. We aim to continuously establish strategic partnerships with platforms that have big
sales potentials and to make customized production according to customer needs.
Summary of Risk Factors
Investing in our ordinary shares involves significant
risks. You should carefully consider all of the information in this prospectus before making an investment in our ordinary shares. Below
please find a summary of the principal risks we face, organized under relevant headings. These risks are discussed more fully in the section
titled “Item 3. Key Information—D. Risk Factors” in our most recent annual
report on Form 20-F.
Risks Related to the Business and Industry
Risks and uncertainties related to our business
and industry include, but are not limited to, the following:
|
· |
We have a history of losses and negative cash flows from operating activities, and we may not achieve or maintain profitability in the future; |
|
· |
We have a limited operating history in the automobile sales business. Our historical financial and operating performance may not be indicative of, or comparable to, its future prospects and results of operations; |
|
· |
Our Dealerships conduct various aspects of
our business, and we face risks associated with our Dealerships, their employees and other personnel; |
|
|
|
|
· |
We may not be able to successfully expand or maintain our network of Dealerships; |
|
· |
Any difficulties in identifying, consummating and integrating acquisitions, investments or alliances may expose us to potential risks and have an adverse effect on our business, results of operations or financial condition; |
|
· |
The quality of the premium used automobiles that our subsidiaries offer is critical to the success of our business; |
|
· |
Our success depends upon the continued contributions of our sales representatives; and |
|
· |
We may need additional capital to pursue our business objectives and respond to business opportunities, challenges or unforeseen circumstances, and financing may not be available on terms acceptable to us, or at all. |
For more
detailed discussions of these risks, see “Item 3. Key Information — D. Risk Factors—Risks Related to Our Business and
Industry” on page 13 to 31 of our annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with
the SEC on May 16, 2023.
Risks Related to Our Corporate Structure
Risks and uncertainties relating to our corporate
structure include, but are not limited to, the following:
c |
· |
Investing in our securities is highly speculative
and involves a significant degree of risk as we are a holding company incorporated in the Cayman Islands and historically operate our
business through VIE structure. To the extent cash or assets in the business are in the PRC/Hong Kong or a PRC/Hong Kong entity, funds
or assets may not be available to fund operations or for other use outside of the PRC/Hong Kong due to interventions in or the imposition
of restrictions and limitations on the ability of the holding company or its subsidiaries by the PRC government to transfer cash or assets.
|
|
· |
Our adjustment of corporate structure and business operations and the termination of contractual arrangements with the VIEs may not be liability-free. |
|
· |
If the custodians or authorized users of our controlling non-tangible assets, including chops and seals, fail to fulfill their responsibilities, or misappropriate or misuse these assets, our business and operations may be materially and adversely affected. See “Item 3. Key Information—D. Risk Factors — Risks Related to Our Corporate Structure — If the custodians or authorized users of our controlling non-tangible assets, including chops and seals, fail to fulfill their responsibilities, or misappropriate or misuse these assets, our business and operations may be materially and adversely affected.” on page 33 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; and |
|
· |
Substantial uncertainties exist with respect to the interpretation and implementation of the PRC Foreign Investment Law, and it may materially and adversely affect the viability of our current corporate structure, corporate governance and business operations. See “Item 3. Key Information—D. Risk Factors — Risks Related to Our Corporate Structure — Substantial uncertainties exist with respect to the interpretation and implementation of the PRC Foreign Investment Law, and it may materially and adversely affect the viability of our current corporate structure, corporate governance and business operations.” on page 33 and 34 of our annual report on Form 20-F for the fiscal year ended December 31, 2022. |
For
more detailed discussions of these risks, see page 32 to 34 of our annual report on Form 20-F for the fiscal year ended December 31,
2022, filed with the SEC on May 16, 2023.
Risks Related to Doing Business in China
We, our subsidiaries and the PRC operating entities
are also subject to risks and uncertainties relating to doing business in China in general, including, but are not limited to, the following:
|
· |
The Chinese government may exercise significant oversight and discretion over the conduct of business in the PRC and may intervene in or influence our operations at any time, which could result in a material change in our operations and/or the value of our securities. See “Risk Factors — Risks Related to Doing Business in China — Uncertainties with respect to the PRC legal system could adversely affect us.” of this prospectus and “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business in China — Chinese government exerts substantial influence over the manner in which we must conduct our business activities. We are required to file with the CSRC within 3 working days after the subsequent securities offering is completed and we might face warnings or fines if we fail to fulfill related filing procedure. We may become subject to more stringent requirements with respect to matters including cross-border investigation and enforcement of legal claims.” on page 34 to 37 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
Uncertainties with respect to the PRC legal system could adversely affect us. The Chinese government may intervene or influence our operations at any time, or may exert more control over offerings conducted overseas and foreign investment in China-based issuers, which could result in a material change in our operations and/or the value of our ordinary shares. In addition, there are significant risks and uncertainties regarding enforcement of laws in China and rules and regulations in China can change quickly with little advance notice. See “Risk Factors — Risks Related to Doing Business in China — Uncertainties with respect to the PRC legal system could adversely affect us.” of this prospectus; |
|
· |
Our ordinary shares may be delisted and prohibited from being traded under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditor. The delisting and the cessation of trading of our ordinary shares, or the threat of their being delisted and prohibited from being traded, may materially and adversely affect the value of your investment. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act. On December 23, 2022, the Accelerating Holding Foreign Companies Accountable Act was enacted, which amended the HFCA Act, by requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three. Our current auditor, Onestop, and our prior auditor for the 2020 and 2021 annual reports, Marcum Asia, the independent registered public accounting firms that issue the financial reports included elsewhere in this prospectus or our most recent annual report on Form 20-F, are registered with the PCAOB. The PCAOB conducts regular inspections to assess their compliance with the applicable professional standards. Onestop and Marcum Asia are headquartered in Singapore and New York, respectively, and, as of the date of this prospectus, are not included in the list of PCAOB Identified Firms in the PCAOB Determinations issued in December 2021. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — If the PCAOB is unable to inspect our auditors as required under the Holding Foreign Companies Accountable Act, the SEC will prohibit the trading of our shares. A trading prohibition for our shares, or the threat of a trading prohibition, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections of our auditors, if any, would deprive our investors of the benefits of such inspections” on page 48 and 49 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
The PRC government’s significant oversight over our business operations could result in a material adverse change in our operations and the value of our ordinary shares. The Chinese government may intervene or influence our operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers. Any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or become worthless. See “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business in China —Chinese government exerts substantial influence over the manner in which we must conduct our business activities. We are required to file with the CSRC within 3 working days after the subsequent securities offering is completed and we might face warnings or fines if we fail to fulfill related filing procedure. We may become subject to more stringent requirements with respect to matters including cross-border investigation and enforcement of legal claims.” on page 34 through 37 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
It may be difficult for overseas shareholders and/or regulators to conduct investigations or collect evidence within China. Furthermore, according to Article 177 of the PRC Securities Law, or Article 177, which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. Accordingly, without governmental approval in China, no entity or individual in China may provide documents and information relating to securities business activities to overseas regulators when it is under direct investigation or evidence discovery conducted by overseas regulators. See “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business in China — It may be difficult for overseas shareholders and/or regulators to conduct investigations or collect evidence within China.” on page 39 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements that we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements that we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.” on page 41 through 42 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may cause a delay in or prevent us from using offshore funds to make loans or additional capital contributions to our PRC subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may cause a delay in or prevent us from using offshore funds to make loans or additional capital contributions to our PRC subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business.” on page 41 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
We are required to obtain certain licenses and permits for our business operations, and we may not be able to obtain or maintain such licenses or permits. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — We are required to obtain certain licenses and permits for our business operations, and we may not be able to obtain or maintain such licenses or permits.” on page 42 and 43 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
PRC regulations relating to offshore investment activities by PRC residents may limit the ability of our PRC subsidiaries to increase their registered capital or distribute profits to us or otherwise expose us or our PRC resident beneficial owners to liability and penalties under PRC laws. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — PRC regulations relating to offshore investment activities by PRC residents may limit the ability of our PRC subsidiaries to increase their registered capital or distribute profits to us or otherwise expose us or our PRC resident beneficial owners to liability and penalties under PRC laws.” on page 45 and 46 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
We face uncertainty with respect to indirect transfers of equity interests in PRC resident enterprises by their non-PRC holding companies, and heightened scrutiny over acquisition transactions by the PRC tax authorities may have a negative impact on potential acquisitions that we may pursue in the future. See “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — We face uncertainty with respect to indirect transfers of equity interests in PRC resident enterprises by their non-PRC holding companies, and heightened scrutiny over acquisition transactions by the PRC tax authorities may have a negative impact on potential acquisitions that we may pursue in the future.” on page 47 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; |
|
· |
You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in this prospectus based on foreign laws. See “D. Risk Factors — Risks Related to Doing Business in China — You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in this prospectus based on foreign laws.” of this prospectus and “Item 3. Key Information—D. Risk Factors — Risks Related to Doing Business in China — You may experience difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in this Annual Report based on foreign laws.” on page 40 of our annual report on Form 20-F for the fiscal year ended December 31, 2022; and |
For more
detailed discussions of these risks, see “Risk Factors—Risks Related to Doing Business in China” of this prospectus
and page 34 to 49 of our annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on
May 16, 2023.
Risks Related to our Ordinary Shares
In addition to the risks and uncertainties described
above, we are subject to risks relating to our ordinary shares, including, but not limited to, the following:
|
· |
The market price movement of our ordinary shares may be volatile; |
|
· |
The sale or availability for sale of substantial amounts of our ordinary shares could adversely affect their market price; and |
|
· |
Because we do not expect to pay dividends in the foreseeable future, you must rely on price appreciation of our ordinary shares for return on your investment. |
For more
detailed discussions of these risks, see “Item 3. Key Information — D. Risk Factors—Risks Related to our Ordinary Shares”
on page 49 to 54 of our annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on May 16,
2023.
Permissions Required
from the PRC Authorities for Our Operations
We
conduct our business through our subsidiaries in China. Our operations in China are governed by PRC laws and regulations. As of the date
of this prospectus, our Company and our subsidiaries have not been involved in any investigations or review initiated by any PRC regulatory
authority, not has any of them received any inquiry, notice or sanction for our operations or our issuance of securities to investors.
Nevertheless, the SCNPC or PRC regulatory authorities may in the future promulgate laws, regulations or implementing rules that
requires us and our subsidiaries to obtain permissions from PRC regulatory authorities to conduct business operations in China.
In addition, as of the
date of this prospectus, except for business license, foreign investment information report to the commerce administrative authority and
foreign exchange registration or filing, our consolidated affiliated Chinese entities do not have to obtain any requisite licenses and
permits from the PRC government authorities that are material for the business operations of our holding company and our subsidiaries
in China. However, given the uncertainties of interpretation and implementation of relevant laws and regulations and the enforcement practice
by government authorities, we may be required to obtain certain licenses, permits, filings or approvals for the functions and services
that we provided in the future.
Dividend Distributions and Cash Transfers within our Organization
Kaixin Auto Holdings transfers cash to its wholly-owned Hong Kong subsidiaries,
by making capital contributions or providing loans, and the Hong Kong subsidiaries transfer cash to the subsidiaries in China by making
capital contributions or providing loans to them. Because Kaixin consolidates the financial statements of the VIEs under the U.S. GAAP
in reliance upon contractual arrangements and is regarded as the primary beneficiary of the VIEs for accounting purposes, Kaixin’s
subsidiaries are not able to make direct capital contribution to the VIEs and their subsidiaries prior to the termination of the VIEs.
However, Kaixin’s subsidiaries may transfer cash to the VIEs by loans or by making payment to the VIEs for inter-group transactions.
Although the Company does not have a formal cash management policy in place that dictates how funds shall be transferred between the Company,
its subsidiaries and the VIEs and its subsidiaries or investors, cash transfers are made among the parties based on business needs in
compliance of relevant PRC laws and regulations. For the years ended December 31, 2020, 2021, and 2022, the VIEs received financial
support for daily operation of nil, US$3.88 million, and US$ 10.79 million from our subsidiaries, and our subsidiaries received financial
support of nil, US$3.90 million, and US$10.49 million from the VIEs and their subsidiaries and of nil, nil, and US$1.25 million from the
parent, respectively. For the years ended December 31, 2020, 2021, and 2022, no assets other than cash were transferred through our
organization.
The cash flows that have occurred between our Company, its subsidiaries
and the VIEs are summarized as follows:
| |
For the year ended December 31,2022 | |
| |
Transfer to | |
| |
| | |
VIEs and their | | |
Non-VIE | |
| |
| | |
Subsidiaries | | |
subsidiaries | |
Transfer from | |
Parent | | |
Consolidated | | |
Consolidated | |
| |
(in thousands) | |
Parent | |
$ | — | | |
$ | — | | |
$ | 1,252 | |
VIEs and their subsidiaries | |
$ | — | | |
$ | — | | |
$ | 10,493 | |
Non-VIE subsidiaries | |
$ | — | | |
$ | 10,793 | | |
$ | — | |
| |
For the year ended December 31,2021 | |
| |
Transfer to | |
| |
| | |
VIEs and their | | |
Non-VIE | |
| |
| | |
Subsidiaries | | |
subsidiaries | |
Transfer from | |
Parent | | |
Consolidated | | |
Consolidated | |
| |
(in thousands) | |
Parent | |
$ | — | | |
$ | — | | |
$ | — | |
VIEs and their subsidiaries | |
$ | — | | |
$ | — | | |
$ | 3,897 | |
Non-VIE subsidiaries | |
$ | — | | |
$ | 3,880 | | |
$ | — | |
| |
For the year ended December 31,2020 | |
| |
Transfer to | |
| |
(in thousands) | |
| |
| | | |
| VIEs and their | | |
| Non-VIE | |
| |
| | | |
| Subsidiaries | | |
| subsidiaries | |
Transfer from | |
| Parent | | |
| Consolidated | | |
| Consolidated | |
Parent | |
$ | — | | |
$ | — | | |
$ | — | |
VIEs and their subsidiaries | |
$ | — | | |
$ | — | | |
$ | — | |
Non-VIE subsidiaries | |
$ | — | | |
$ | — | | |
$ | — | |
For the years ended December 31,
2020, 2021 and 2022 , no dividends or distributions were made to the Company by our subsidiaries. Under PRC laws and regulations, our
PRC subsidiaries are subject to certain restrictions with respect to paying dividends or otherwise transferring any of their net assets
to us. Remittance of dividends by a wholly foreign-owned enterprise out of China is also subject to examination by the banks designated
by SAFE. The amounts restricted include the paid-up capital and the statutory reserve funds of our PRC subsidiaries and historically owned
VIEs , totaling US$7.6 million, US$117.1 million, US$121.7 million as of December 31, 2020, 2021 and 2022, respectively. Furthermore,
cash transfers from our PRC subsidiaries to entities outside of China are subject to PRC government control of currency conversion. Shortages
in the availability of foreign currency may temporarily delay the ability of our PRC subsidiaries to remit sufficient foreign currency
to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated obligations. For risks relating to the
fund flows of our operations in China, see “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business
in China — We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing
requirements that we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material
and adverse effect on our ability to conduct our business.” of our annual report for the fiscal year ended December 31, 2022,
filed with the SEC on May 16, 2023. Additionally, the PRC government imposes controls on the convertibility of Renminbi into foreign
currencies and, in certain cases, the remittance of currency out of China. If the foreign exchange control system prevents us from obtaining
sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to pay dividends in foreign currencies to our
shareholders. See “Item 3. Key Information — D. Risk Factors — Risks Related
to Doing Business in China — PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and
governmental control of currency conversion may cause a delay in or prevent us from using offshore funds to make loans or additional capital
contributions to our PRC subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our
business.” of our annual report for the fiscal year ended December 31, 2022, filed with the SEC on May 16, 2023.
We have not declared or paid
any cash dividends, nor do we have any present plan to pay any cash dividends on our ordinary shares in the foreseeable future.
We currently
intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business.
Our PRC subsidiaries are permitted to pay dividends
only out of their retained earnings. However, each of our PRC subsidiaries is required to set aside at least 10% of its after-tax profits
each year, after making up for previous year’s accumulated losses, if any, to fund certain statutory reserves, until the aggregate
amount of such funds reaches 50% of its registered capital. This portion of our PRC subsidiaries’ respective net assets are prohibited
from being distributed to their shareholders as dividends. However, none of our subsidiaries has made any dividends or distributions to
us or to any U.S. investors as of the date of this prospectus.
A 10% PRC withholding tax is applicable to dividends
payable to investors that are non-resident enterprises. Any gain realized on the transfer of ordinary shares by such investors is also
subject to PRC tax at a current rate of 10%, which in case of dividends will be withheld at source if such gain is regarded as income
derived from sources within the PRC. See “Item 3. Key Information — Risk Factors — Risks Related to Doing Business in
China — If we are classified as a PRC resident enterprise for PRC income tax purposes, such classification could result in unfavorable
tax consequences to us and our non-PRC shareholders.” included in our most recent annual report on Form 20-F.
Financial Information Related to the VIEs
The following tables present the condensed
consolidating schedule of financial information for our Company, our subsidiaries, the VIEs and the VIEs’ subsidiaries for the periods
indicated.
Disaggregated Financial Information relating
to the VIEs
Selected Condensed Consolidated Balance
Sheet Data
| |
As of December 31, 2022 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Total current assets | |
$ | 13,727 | | |
$ | 32,301 | | |
$ | — | | |
$ | (3,726 | ) | |
$ | 42,302 | |
Investments in subsidiaries and VIEs | |
$ | 27,964 | | |
$ | — | | |
$ | — | | |
$ | (27,964 | ) | |
$ | — | |
Total non-current assets | |
$ | 27,964 | | |
$ | 13,380 | | |
$ | — | | |
$ | (27,964 | ) | |
$ | 13,380 | |
Total assets | |
$ | 41,691 | | |
$ | 45,681 | | |
$ | — | | |
$ | (31,690 | ) | |
$ | 55,682 | |
Total current liabilities | |
$ | 10,376 | | |
$ | 13,219 | | |
$ | — | | |
$ | (3,726 | ) | |
$ | 19,869 | |
Total non-current liabilities | |
$ | — | | |
$ | 311 | | |
$ | — | | |
$ | — | | |
$ | 311 | |
Total liabilities | |
$ | 10,376 | | |
$ | 13,529 | | |
$ | — | | |
$ | (3,726 | ) | |
$ | 20,179 | |
| |
As of December 31, 2021 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Amount due from VIE | |
$ | — | | |
$ | 42,495 | | |
$ | — | | |
$ | (42,495 | ) | |
$ | — | |
Total current assets | |
$ | — | | |
$ | 49,449 | | |
$ | 51,983 | | |
$ | (42,495 | ) | |
$ | 58,937 | |
Investments in subsidiaries and VIEs | |
$ | 5,130 | | |
$ | — | | |
$ | — | | |
$ | (5,130 | ) | |
$ | — | |
Total non-current assets | |
$ | 5,130 | | |
$ | 14,897 | | |
$ | 326 | | |
$ | (5,130 | ) | |
$ | 15,223 | |
Total assets | |
$ | 5,130 | | |
$ | 64,346 | | |
$ | 52,309 | | |
$ | (47,625 | ) | |
$ | 74,160 | |
Amount due to non-VIE | |
$ | — | | |
$ | — | | |
$ | 42,495 | | |
$ | (42,495 | ) | |
$ | — | |
Total current liabilities | |
$ | — | | |
$ | 52,518 | | |
$ | 19,360 | | |
$ | (42,495 | ) | |
$ | 29,383 | |
Total non-current liabilities | |
$ | — | | |
$ | 6,698 | | |
$ | — | | |
$ | — | | |
$ | 6,698 | |
Total liabilities | |
$ | — | | |
$ | 59,216 | | |
$ | 19,360 | | |
$ | (42,495 | ) | |
$ | 36,081 | |
Selected Condensed Consolidated Statement
of Operations Data
| |
For the years ended December 31,2022 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Revenue | |
$ | — | | |
$ | 52,962 | | |
$ | 29,878 | | |
$ | — | | |
$ | 82,840 | |
Cost of revenue | |
$ | — | | |
$ | 52,617 | | |
$ | 29,577 | | |
$ | — | | |
$ | 82,194 | |
Gross profit | |
$ | — | | |
$ | 345 | | |
$ | 301 | | |
$ | — | | |
$ | 646 | |
Operating expenses | |
$ | 5,897 | | |
$ | 7,605 | | |
$ | 35,083 | | |
$ | — | | |
$ | 48,585 | |
Loss from operations | |
$ | (6,363 | ) | |
$ | (6,519 | ) | |
$ | (35,057 | ) | |
$ | — | | |
$ | (47,939 | ) |
Share of loss from subsidiaries | |
$ | (78,256 | ) | |
$ | — | | |
$ | — | | |
$ | 78,256 | | |
$ | — | |
Net loss | |
$ | (84,619 | ) | |
$ | (61,368 | ) | |
$ | (16,888 | ) | |
$ | 78,256 | | |
$ | (84,619 | ) |
Less: net loss attributable to non-controlling interests | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
Net loss attributable to the Company’s shareholders | |
$ | (84,619 | ) | |
$ | (61,455 | ) | |
$ | (16,888 | ) | |
$ | 78,256 | | |
$ | (84,706 | ) |
| |
For the year ended December 31,2021 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Revenue | |
$ | — | | |
$ | — | | |
$ | 253,840 | | |
$ | — | | |
$ | 253,840 | |
Cost of revenue | |
$ | — | | |
$ | — | | |
$ | 248,583 | | |
$ | | | |
$ | 248,583 | |
Gross profit | |
$ | — | | |
$ | — | | |
$ | 5,257 | | |
$ | — | | |
$ | 5,257 | |
Operating expenses | |
$ | — | | |
$ | 186,691 | | |
$ | 1,179 | | |
$ | | | |
$ | 187,870 | |
(Loss) income from operations | |
$ | — | | |
$ | (186,691 | ) | |
$ | 4,078 | | |
$ | | | |
$ | (182,613 | ) |
Share of loss from subsidiaries | |
$ | (195,228 | ) | |
$ | (68 | ) | |
$ | — | | |
$ | 195,296 | | |
$ | — | |
Net loss | |
$ | (195,228 | ) | |
$ | (195,160 | ) | |
$ | (768 | ) | |
$ | 195,296 | | |
$ | (195,928 | ) |
Less: net income attributable to non-controlling
interests | |
$ | | | |
$ | | | |
$ | 651 | | |
$ | | | |
$ | 651 | |
Net loss attributable to the Company’s
shareholders | |
$ | (195,228 | ) | |
$ | (195,160 | ) | |
$ | (1,419 | ) | |
$ | 195,296 | | |
$ | (196,579 | ) |
| |
For the years ended December 31,2020 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Revenue | |
$ | — | | |
$ | — | | |
$ | 1,207 | | |
$ | — | | |
$ | 1,207 | |
Cost of revenue | |
$ | — | | |
$ | — | | |
$ | 1,207 | | |
$ | — | | |
$ | 1,207 | |
Gross profit | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
Operating expenses | |
$ | — | | |
$ | — | | |
$ | 276 | | |
$ | — | | |
$ | 276 | |
Loss from operations | |
$ | — | | |
$ | — | | |
$ | (276 | ) | |
$ | — | | |
$ | (276 | ) |
Share of loss from subsidiaries | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
Net loss | |
$ | — | | |
$ | — | | |
$ | (166 | ) | |
$ | — | | |
$ | (166 | ) |
Less: net loss attributable to non-controlling interests | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
Net loss attributable to the Company’s shareholders | |
$ | — | | |
$ | — | | |
$ | (166 | ) | |
$ | — | | |
$ | (166 | ) |
Selected Consolidated Statement of Cash
Flows
| |
For the year ended December 31,2022 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Net cash provided by operating activities | |
$ | (2,410 | ) | |
$ | 404 | | |
$ | (388 | ) | |
$ | — | | |
$ | (2,394 | ) |
Net cash (used in) provided by investing activities | |
$ | — | | |
$ | (156 | ) | |
$ | — | | |
$ | — | | |
$ | (156 | ) |
Net cash used in by financing activities | |
$ | (165 | ) | |
$ | 5,386 | | |
$ | 185 | | |
$ | — | | |
$ | 5,406 | |
Effect of exchange rate changes | |
$ | — | | |
$ | — | | |
$ | (1,017 | ) | |
$ | — | | |
$ | (1,017 | ) |
Net increase (decrease) in cash, cash equivalents and restricted cash | |
$ | (2,575 | ) | |
$ | 5,634 | | |
$ | (1,220 | ) | |
$ | — | | |
$ | 1,839 | |
| |
For the year ended December 31,2021 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Net cash provided by (used in) operating activities | |
$ | — | | |
$ | 989 | | |
$ | (3,092 | ) | |
$ | — | | |
$ | (2,103 | ) |
Net cash (used in) provided by investing activities | |
$ | — | | |
$ | (6,332 | ) | |
$ | 2,822 | | |
$ | 7,777 | | |
$ | 4,267 | |
Net cash provided by financing activities | |
$ | — | | |
$ | 9,777 | | |
$ | — | | |
$ | (7,777 | ) | |
$ | 2,000 | |
Effect of exchange rate changes | |
$ | — | | |
$ | — | | |
$ | 492 | | |
$ | | | |
$ | 492 | |
Net increase in cash, cash equivalents and restricted cash | |
$ | — | | |
$ | 4,434 | | |
$ | 222 | | |
$ | — | | |
$ | 4,656 | |
| |
For the years ended December 31,2020 | |
| |
| | |
Non-VIE | | |
VIEs and their | | |
| | |
| |
| |
Parent | | |
Subsidiaries | | |
subsidiaries | | |
Inter-company | | |
Group | |
| |
Company | | |
Consolidated | | |
Consolidated | | |
elimination | | |
Consolidation | |
| |
(in thousands) | |
Net cash used in operating activities | |
$ | — | | |
$ | — | | |
$ | (1,135 | ) | |
$ | — | | |
$ | (1,135 | ) |
Net cash used in investing activities | |
$ | — | | |
$ | — | | |
$ | (290 | ) | |
$ | — | | |
$ | (290 | ) |
Net cash provided by financing activities | |
$ | — | | |
$ | — | | |
$ | 2,132 | | |
$ | — | | |
$ | 2,132 | |
Effect of exchange rate changes | |
$ | | | |
$ | | | |
$ | (104 | ) | |
$ | | | |
$ | (104 | ) |
Net increase in cash, cash equivalents and restricted cash | |
$ | — | | |
$ | — | | |
$ | 603 | | |
$ | — | | |
$ | 603 | |
Corporate Information
Our principal executive offices are located at
9/F, Tower A, Dongjin International Center, Huagong Road, Chaoyang District, Beijing 100015, People’s Republic of China. Our telephone
number at this address is +86 10 6720 4948. Our registered office is situated at the office of Harneys Fiduciary (Cayman) Limited, 4th
Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands. Our agent for service of process
in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168.
Investors should submit any inquiries to the
address or through the telephone number of our principal executive offices. Our main website is http://ir.kaixin.com.
The information
contained on our website is not a part of this prospectus.
RISK FACTORS
Investing
in our securities involves risks. Before making an investment decision, you should carefully consider the risks described under “Risk
Factors” below, in the applicable prospectus supplement and under the heading “Item 3. Key Information—D. Risk Factors”
in our annual report on Form 20-F for the fiscal year ended December 31, 2022, or any updates in our reports on Form 6-K,
together with all of the other information appearing in, or incorporated by reference into, under the Exchange Act that are incorporated
herein by reference into, this prospectus and any applicable prospectus supplement, in light of your particular investment objectives
and financial circumstances. In addition to those risk factors, there may be additional risks and uncertainties of which management is
not aware or focused on or that management deems immaterial. Our business, financial condition, or results of operations could be materially
adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose
all or part of your investment. See the sections of this prospectus entitled “Where You Can Find More Information” and “Incorporation
of Certain Information by Reference.”
Risks Related to Our Corporate Structure
Our adjustment of corporate structure and business operations
and the termination of contractual arrangement with the VIEs may not be liability-free.
With the disposition of Renren Finance Inc.,
all VIEs were disposed as of October 27, 2022. We cannot assure you that the disposal of the affiliated entities and termination
of contractual arrangement with the related VIE structures in the PRC will not give rise to dispute or liability, or that such disposal
and discontinuation of operations will not adversely affect our overall results of operations and financial condition. We cannot guarantee
that we will not continue to be subject to PRC regulatory inspection and/or review, especially when there remains significant uncertainty
as to the scope and manner of the regulatory enforcement. If we become subject to regulatory inspection and/or review by the China Securities
Regulatory Commission, or the CSRC, Cyberspace Administration of China, or the CAC or other PRC authorities, or are required by them
to take any specific actions, it could cause suspension or termination of the future offering of our securities, disruptions to our operations,
result in negative publicity regarding our company, and divert our managerial and financial resources.
Investing in our securities is highly speculative
and involves a significant degree of risk as we are a holding company incorporated in the Cayman Islands and historically operate our
business through VIE structure. To the extent cash or assets in the business are in the PRC/Hong Kong or a PRC/Hong Kong entity, funds
or assets may not be available to fund operations or for other use outside of the PRC/Hong Kong due to interventions in or the imposition
of restrictions and limitations on the ability of the holding company or its subsidiaries by the PRC government to transfer cash or assets.
We
a holding company with no material operations of our own. Historically, we conducted our operations through our subsidiaries and the
VIEs and their subsidiaries organized under the laws of the PRC, with which our subsidiaries maintain certain contractual arrangements.
These contractual arrangements, which were not equivalent to equity ownership in the business of the VIEs, enabled us to consolidate
the financial statements of the VIEs and their subsidiaries under U.S. GAAP and we were regarded as the primary beneficiary of the VIEs
for accounting purposes. The structure involves unique risks to investors. The VIE structure provides contractual exposure to foreign
investment in China-based companies where Chinese law prohibits direct foreign investment in the operating companies. To mitigate the
risks, we transferred operations in the VIEs to our wholly-owned entities and disposed of Renren Finance, Inc., which was our wholly-owned
subsidiary that contractually controls the VIEs. See “Item 3. Key Information — Risk Factors — Risks Related
to Our Corporate Structure — Our adjustment of corporate structure and business operations and the termination of contractual arrangement
with the VIEs may not be liability-free.” and “Item 4. Information on the Company — C. Organizational Structure.”
of our most recent annual report on Form 20-F.
In addition, any actions by the Chinese government
to exert more oversight and control over securities that are listed overseas or foreign investment in China-based issuers could significantly
limit or completely hinder our ability to continue to offer securities to investors and cause the value of our securities to significantly
decline or be worthless.
Moreover,
we have no operations outside PRC, and cash generated from operations in the PRC may not be available for other use outside of the PRC
due to interventions in or the imposition of restrictions and limitations on the ability of us or our subsidiaries by the PRC government
to transfer cash. The transfer of funds and assets among us and our Hong Kong and PRC subsidiaries is subject to restrictions. The PRC
government imposes controls on the conversion of the RMB into foreign currencies and the remittance of currencies out of the PRC. In
addition, the PRC Enterprise Income Tax Law and its implementation rules provide that a withholding tax at a rate of 10% will be
applicable to dividends payable by Chinese companies to non-PRC-resident enterprises, unless reduced under treaties or arrangements between
the PRC central government and the governments of other countries or regions where the non-PRC resident enterprises are tax resident.
As of the date of this prospectus, there are no restrictions or limitations imposed by the Hong Kong government on the transfer
of capital within, into and out of Hong Kong (including funds from Hong Kong to the PRC), except for the transfer of funds involving
money laundering and criminal activities. However, there is no guarantee that the Hong Kong government will not promulgate new laws or
regulations that may impose such restrictions in the future. As a result of the above, to the extent cash or assets of our business,
or of the PRC operating entities, is in the PRC or Hong Kong, such funds or assets may not be available to fund operations or for other
use outside of the PRC or Hong Kong, due to interventions in or the imposition of restrictions and limitations by the PRC government
to the transfer of cash or assets.
Risks Related to Doing Business in China
The Chinese government exerts substantial
influence over the manner in which we must conduct our business activities. We are required to file with the CSRC within 3 working days
after the subsequent securities offering is completed and we might face warnings or fines if we fail to fulfill related filing procedure.
We may become subject to more stringent requirements with respect to matters including cross-border investigation and enforcement of
legal claims.
The Chinese government has exercised and continues
to exercise substantial control over virtually every sector of the Chinese economy through regulation and state ownership. Under the
current government leadership, the government of the PRC has been pursuing reform policies which have adversely affected China-based
operating companies whose securities are listed in the United States, with significant policies changes being made from time to time
without notice. There are substantial uncertainties regarding the interpretation and application of PRC laws and regulations, including,
but not limited to, the laws and regulations governing our business, or the enforcement and performance of our contractual arrangements
with borrowers in the event of the imposition of statutory liens, death, bankruptcy or criminal proceedings. Our ability to operate in
China may be harmed by changes in its laws and regulations, including those relating to taxation, environmental regulations, land use
rights, property and other matters. The central or local governments of these jurisdictions may impose new, stricter regulations or interpretations
of existing regulations that would require additional expenditures and efforts on our part to ensure our compliance with such regulations
or interpretations. Accordingly, government actions in the future, including any decision not to continue to support recent economic
reforms and to return to a more centrally planned economy or regional or local variations in the implementation of economic policies,
could have a significant effect on economic conditions in China or particular regions thereof, and could require us to divest ourselves
of any interest we then hold in Chinese properties.
Given recent statements by the Chinese government
indicating an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based
issuers, any such action could significantly limit or completely hinder our ability to offer or continue to offer securities to investors
and cause the value of such securities to significantly decline or become worthless.
The
General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued the
Opinions on Severely Cracking Down on Illegal Securities Activities on July 6, 2021. The Opinions emphasized the need to strengthen
the administration over illegal securities activities, and the need to strengthen the supervision over overseas listings by Chinese companies.
Effective measures, such as promoting the construction of relevant regulatory systems, will be taken to deal with the risks and incidents
of China-concept overseas listed companies. As of the date of this prospectus, we have not received any inquiry, notice, warning,
or sanctions from PRC government authorities in connection with the Opinions.
On June 10, 2021, the SCNPC, promulgated
the PRC Data Security Law, which took effect in September 2021. The PRC Data Security Law imposes data security and privacy obligations
on entities and individuals carrying out data activities, and introduces a data classification and hierarchical protection system based
on the importance of data in economic and social development, and the degree of harm it will cause to national security, public interests,
or legitimate rights and interests of individuals or organizations when such data is tampered with, destroyed, leaked, illegally acquired
or used. The PRC Data Security Law also provides for a national security review procedure for data activities that may affect national
security and imposes export restrictions on certain data an information.
In early July 2021, regulatory authorities
in China launched cybersecurity investigations with regard to several China-based companies that are listed in the United States. The
Chinese cybersecurity regulator announced on July 2, 2021 that it had begun an investigation of Didi Global Inc. (NYSE: DIDI) and
two days later ordered that the company’s app be removed from smartphone app stores. On July 5, 2021, the Chinese cybersecurity
regulator launched the same investigation on two other Internet platforms, China’s Full Truck Alliance of Full Truck Alliance Co.
Ltd. (NYSE: YMM) and Boss of KANZHUN LIMITED (Nasdaq: BZ). On July 24, 2021, the General Office of the Communist Party of China
Central Committee and the General Office of the State Council jointly released the Guidelines for Further Easing the Burden of Excessive
Homework and Off-campus Tutoring for Students at the Stage of Compulsory Education, pursuant to which foreign investment in such firms
via mergers and acquisitions, franchise development, and variable interest entities are banned from this sector.
On August 17, 2021, the State Council promulgated
the Regulations on the Protection of the Security of Critical Information Infrastructure (the “Regulations”), which took
effect on September 1, 2021. The Regulations supplemented and specified the provisions on the security of critical information infrastructure
as stated in the Cybersecurity Review Measures, which was issued on April 13, 2020 and was amended on December 28, 2021. The
Regulations provide, among others, that protection department of certain industry or sector shall notify the operator of the critical
information infrastructure in time after the identification of certain critical information infrastructure.
On August 20, 2021, the SCNPC promulgated
the Personal Information Protection Law of the PRC (the “Personal Information Protection Law”), which took effect in November 2021.
As the first systematic and comprehensive law specifically for the protection of personal information in the PRC, the Personal Information
Protection Law provides, among others, that (i) an individual’s consent shall be obtained to use sensitive personal information,
such as biometric characteristics and individual location tracking; (ii) personal information operators using sensitive personal
information shall notify individuals of the necessity of such use and impact on the individual’s rights; and (iii) where personal
information operators reject an individual’s request to exercise his or her rights, the individual may file a lawsuit with a People’s
Court.
As such, the Company’s business segments
may be subject to various government and regulatory interference in the provinces in which they operate. The Company could be subject
to regulations by various political and regulatory entities, including various local and municipal agencies and government sub-divisions.
The Company may incur increased costs necessary to comply with the existing and newly adopted laws and regulations or penalties for any
failure to comply. Additionally, the governmental and regulatory interference could significantly limit or completely hinder our ability
to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.
Furthermore, we are required to file with the
CSRC within 3 working days after the subsequent securities offering is completed and we might face warnings or fines if we fail to fulfill
related filing procedure. Although there are still uncertainties regarding the interpretation and implementation of relevant regulatory
guidance, our operations could be adversely affected, directly or indirectly, by existing or future laws and regulations relating to
its business or industry.
On February 17, 2023, the China Securities
Regulatory Commission, or the CSRC, promulgated Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic
Companies (the “Overseas Listing Trial Measures”) and five relevant guidelines which became effective on March 31, 2023.
The Overseas Listing Trial Measures regulate both direct and indirect overseas offering and listing by PRC domestic companies by adopting
a filing-based regulatory regime.
The Overseas Listing Trial Measures provide
that if the issuer both meets the following criteria, the overseas securities offering and listing conducted by such issuer will be
deemed as indirect overseas offering subject to the filing procedure set forth under the Overseas Listing Trial Measures:
(i) 50% or more of the issuer’s operating revenue, total profit, total assets or net assets as documented in its audited
consolidated financial statements for the most recent fiscal year is accounted for by the issuer’s domestic companies; and
(ii) the issuer’s business activities are substantially conducted in mainland China, or its principal place of business
are located in mainland China, or the senior managers in charge of its business operations and management are mostly Chinese
citizens or domiciled in mainland China. The determination as to whether or not an overseas offering and listing by domestic
companies is indirect, shall be made on a substance over form basis.
On
the same day, the CSRC also held a press conference for the release of the Trial Measures and issued the Notice on Administration for
the Filing of Overseas Offering and Listing by Domestic Companies, which, among others, clarifies that on or prior to the effective date
of the Overseas Listing Trial Measures, domestic companies that have been completed their overseas offering and listing, which are called
as “the stock enterprises (存量企业)”.
As a stock enterprise (存量企业), we shall file
with the CSRC within 3 working days after the subsequent securities offering is completed. The CSRC shall order rectification, issue
warnings and impose fines to the company fails to fulfill filing procedure as stipulated in Overseas Listing Trial Measures.
In addition, the CSRC published the Provisions
on Strengthening Confidentiality and Archives Administration in Respect of Overseas Issuance and Listing of Securities by Domestic Enterprises
on February 24, 2023, which became effective on March 31, 2023. The CSRC stipulates domestic enterprises, securities companies
and securities service agencies which provide the corresponding services in the course of overseas issuance and listing of domestic enterprises,
shall strengthen legal awareness of confidentiality of State secrets and archives administration, establish a sound system for confidentiality
and archives work, adopt the requisite measures to perform the responsibilities of confidentiality and archives administration.
As there are still uncertainties regarding the
interpretation and implementation of such regulatory guidance, we cannot assure you that we will always be able to comply with new regulatory
requirements relating to our future overseas capital-raising activities. We may become subject to more stringent requirements with respect
to matters including cross-border investigation and enforcement of legal claims.
In
addition, on December 28, 2021, the CAC, the National Development and Reform Commission (“NDRC”), and several other
administrations jointly issued the revised Measures for Cybersecurity Review (the “Revised Review Measures”), which became
effective and replaced the Measures for Cybersecurity Review on February 15, 2022. According to the Revised Review Measures, if
an “online platform operator” that is in possession of personal data of more than one million users intends to list in a
foreign country, it must apply for a cybersecurity review. Based on a set of Q&A published on the official website of the State Cipher
Code Administration in connection with the issuance of the Revised Review Measures, an official of the said administration indicated
that an online platform operator should apply for a cybersecurity review prior to the submission of its listing application with non-PRC
securities regulators. Given the recency of the issuance of the Revised Review Measures, there is a general lack of guidance and substantial
uncertainties exist with respect to their interpretation and implementation. For example, it is unclear whether the requirement of cybersecurity
review applies to follow-on offerings by an “online platform operator” that is in possession of personal data of more than
one million users where the offshore holding company of such operator that is already listed overseas. Furthermore, the CAC released
the draft of the Regulations on Network Data Security Management (the “Draft Regulations”) in November 2021 for public
consultation, which among other things, stipulates that a data processor listed overseas must conduct an annual data security review
by itself or by engaging a data security service provider and submit the annual data security review report for a given year to the municipal
cybersecurity department before January 31 of the following year. On July 7, 2022, CAC promulgated Measures for the Measures
on Outbound Data Transfer, which became effective on September 1, 2022 and provide that a data processor is required to apply
for security assessment for cross-border data transfer in any of the following circumstances: (i) where a data processor provides
critical data to offshore entities and individuals; (ii) where a CIIO or a data processor which processes personal information of
more than one million individuals provides personal information to offshore entities and individuals; (iii) where a data processor
has provided personal information in the aggregate of more than 100,000 individuals or sensitive personal information of more than 10,000
individuals in total to offshore entities and individuals since January 1 of the previous year; or (iv) other circumstances
prescribed by the CAC for which declaration for security assessment for cross-board transfer of data is required. Furthermore, on August 31,
2022, the CAC promulgated the Guidelines for filing the Outbound Data Transfer Security Assessment (Version 1), which provides that acts
of outbound data transfer include (i) overseas transmission and storage by data processors of data generated during mainland China
domestic operations; (ii) the access to, use, download or export of the data collected and generated by data processors and stored
in mainland China by overseas institutions, organizations or individuals; and (iii) other acts as specified by the CAC. The Revised
Review Measures and the Draft Regulations remain unclear on whether the relevant requirements will be applicable to companies, which
have been listed in the United States, such as us. They also remain uncertain whether the future regulatory changes would impose additional
restrictions on companies like us. We cannot predict the impact of the Revised Review Measures and the Draft Regulations, if any, at
this stage, and we will closely monitor and assess any development in the rule-making process.
We have been closely monitoring the development
in the regulatory landscape in China, particularly regarding the requirement of approvals, including on a retrospective basis, from the
CSRC, the CAC or other PRC authorities, as well as regarding any annual data security review or other procedures that may be imposed
on us. If any approval, review or other procedure is in fact required, we are not able to guarantee that we will obtain such approval
or complete such review or other procedure timely or at all. For any approval that we may be able to obtain, it could nevertheless be
revoked and the terms of its issuance may impose restrictions on our operations and offerings relating to our securities.
Uncertainties with respect to the PRC legal
system could adversely affect us.
The PRC legal system is based on written statutes.
Unlike under common law systems, decided legal cases have little value as precedents in subsequent legal proceedings. In 1979, the PRC
government began to promulgate a comprehensive system of laws and regulations governing economic matters in general and forms of foreign
investment (including in respect of wholly foreign owned enterprises) in particular. These laws, regulations and legal requirements are
relatively new and are often changing, and their interpretation and enforcement depend to a large extent on relevant government policy
and involve significant uncertainties that could limit the reliability of the legal protections available to us.
The Chinese government may intervene or
influence our operations at any time, which could result in a material change in our operations and/or the value of our ordinary
shares. In addition, there are significant risks and uncertainties regarding enforcement of laws in China and rules and
regulations in China can change quickly with little advance notice. In 2021, the PRC government initiated a series of regulatory
actions and statements to regulate business operations in China with little advance notice, including cracking down on illegal
activities in the securities market, enhancing supervision over China-based companies listed overseas, adopting new measures to
extend the scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. Since these statements and
regulatory actions are new, it is highly uncertain how soon legislative or administrative regulation making bodies will respond and
what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, if any,
and the potential impact such modified or new laws and regulations will have on our daily business operation, the ability to accept
foreign investments and list on an U.S. or other foreign exchange.
We cannot predict the effects of future developments
in government policy or the PRC legal system in general. We may be required in the future to procure additional permits, authorizations
and approvals for our existing and future operations, which may not be obtainable in a timely fashion or at all, or may involve substantial
costs and unforeseen risks. An inability to obtain, or the incurrence of substantial costs in obtaining, such permits, authorizations
and approvals may have a material adverse effect on our business, financial condition and results of operations.
Recent regulatory
initiatives implemented by the PRC competent government authorities on cyberspace data security may have introduced uncertainty in our
business operations and compliance status, which could result in materially adverse impact on our business, results of operations, our
listing on Nasdaq, and this offering.
On February 17, 2023, the China Securities
Regulatory Commission, or the CSRC, promulgated Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic
Companies (the “Overseas Listing Trial Measures”) and five relevant guidelines which became effective on March 31, 2023.
The Overseas Listing Trial Measures regulate both direct and indirect overseas offering and listing by PRC domestic companies by adopting
a filing-based regulatory regime.
The Overseas Listing Trial Measures provide that
if the issuer both meets the following criteria, the overseas securities offering and listing conducted by such issuer will be deemed
as indirect overseas offering subject to the filing procedure set forth under the Overseas Listing Trial Measures: (i) 50% or more
of the issuer’s operating revenue, total profit, total assets or net assets as documented in its audited consolidated financial
statements for the most recent fiscal year is accounted for by the issuer’s domestic companies; and (ii) the issuer’s
business activities are substantially conducted in mainland China, or its principal place of business are located in mainland China,
or the senior managers in charge of its business operations and management are mostly Chinese citizens or domiciled in mainland China.
The determination as to whether or not an overseas offering and listing by domestic companies is indirect, shall be made on a substance
over form basis.
On
the same day, the CSRC also held a press conference for the release of the Trial Measures and issued the Notice on Administration for
the Filing of Overseas Offering and Listing by Domestic Companies, which, among others, clarifies that on or prior to the effective date
of the Overseas Listing Trial Measures, domestic companies that have been completed their overseas offering and listing, which are called
as “the stock enterprises (存量企业)”.
As a stock enterprise (存量企业), we shall file
with the CSRC within 3 working days after the subsequent securities offering is completed. The CSRC shall order rectification, issue
warnings and impose fines to the company fails to fulfill filing procedure as stipulated in Overseas Listing Trial Measures.
In addition, the CSRC published the Provisions
on Strengthening Confidentiality and Archives Administration in Respect of Overseas Issuance and Listing of Securities by Domestic Enterprises
on February 24, 2023, which became effective on March 31, 2023. The CSRC stipulates domestic enterprises, securities companies
and securities service agencies which provide the corresponding services in the course of overseas issuance and listing of domestic enterprises,
shall strengthen legal awareness of confidentiality of State secrets and archives administration, establish a sound system for confidentiality
and archives work, adopt the requisite measures to perform the responsibilities of confidentiality and archives administration.
As there are still uncertainties regarding the
interpretation and implementation of such regulatory guidance, we cannot assure you that we will always be able to comply with new regulatory
requirements relating to our future overseas capital-raising activities. We may become subject to more stringent requirements with respect
to matters including cross-border investigation and enforcement of legal claims.
In addition, the General Office of the Central
Committee of the Communist Party of China and the General Office of the State Council jointly issued the “Opinions on Severely
Cracking Down on Illegal Securities Activities According to Law,” or the Opinions, which was made available to the public on July 6,
2021. The Opinions emphasized the need to strengthen the administration over illegal securities activities, and the need to strengthen
the supervision over overseas listings by Chinese companies. Effective measures, such as promoting the construction of relevant regulatory
systems will be taken to deal with the risks and incidents of China-concept overseas listed companies, and cybersecurity and data privacy
protection requirements and similar matters.
However, given the recency of the rules, there
are uncertainties in the enforcements of the rule and we have been closely monitoring the development in the regulatory landscape
in China, particularly regarding the requirement of approvals, including on a retrospective basis, from the CSRC or other PRC authorities.
It also remains uncertain whether any future regulatory changes would impose additional restrictions on companies such as ours. Thus,
it is still uncertain how PRC governmental authorities will regulate overseas listing in general and whether we are required to obtain
any specific regulatory approvals. Furthermore, if the China Securities Regulatory Commission, or the CSRC or other regulatory agencies
later promulgate new rules or explanations requiring that we obtain their approvals for this offering and any follow-on offering,
we may be unable to obtain such approvals which could significantly limit or completely hinder our ability to offer or continue to offer
securities to our investors. We may not be able to guarantee that we will obtain such approval or complete such review or other procedure
timely or at all. For any approval that we may be able to obtain, it could nevertheless be revoked and the terms of its issuance may
impose restrictions on our operations and offerings relating to our securities.
It may be difficult for overseas shareholders
and/or regulators to conduct investigations or collect evidence within China.
Shareholder claims or regulatory
investigation that are common in the United States generally are difficult to pursue as a matter of law or practicality in China.
For example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations
or litigation initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the
securities regulatory authorities of another country or region to implement cross-border supervision and administration, such
cooperation with the securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and
practical cooperation mechanism. Furthermore, according to Article 177 of the PRC Securities Law, or Article 177, which
became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence
collection activities within the territory of the PRC. Accordingly, without governmental approval in China, no entity or individual
in China may provide documents and information relating to securities business activities to overseas regulators when it is under
direct investigation or evidence discovery conducted by overseas regulators. While detailed interpretation of or implementation
rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator to directly conduct
investigation or evidence collection activities within China may further increase difficulties faced by you in protecting your
interests.
You may experience difficulties in effecting
service of legal process, enforcing foreign judgments or bringing actions in China against us or our management named in this prospectus
based on foreign laws.
We
are a company incorporated under the laws of the Cayman Islands, we conduct all of our operations in China and all of our assets are
located in China. In addition, except for our chief financial officer and director, Ms. Yi Yang, who is a U.S. citizen, all other
officers and directors are PRC nationals. All of our officers and directors reside within China, namely our chairman and chief executive
officer, Mr. Mingjun Lin, our chief financial officer, Yi Yang, and our directors Mr. Deqiang Chen, Mr. Xiaolei Gu, and
Mr. Lin Cong. All or a substantial portion of the assets of these persons are located outside the United States. As a result, it
may be difficult to effect service of process within the United States upon these persons. See “Item 6. Directors, Senior Management
and Employees – A. Directors and senior management” of our annual report on Form 20-F for the fiscal year ended December 31, 2022.
In addition, there is uncertainty as to whether
the courts of the Cayman Islands and other jurisdictions would recognize or enforce judgments of United States courts obtained against
us or such persons predicated upon the civil liability provisions of the securities laws of the United States or any state thereof, or
be competent to hear original actions brought in the Cayman Islands or other jurisdictions against us or such persons predicated upon
the securities laws of the United States or any of our state. In particular, China does not have treaties providing for the reciprocal
recognition and enforcement of judgments of courts with the Cayman Islands and many other countries and regions. Therefore, recognition
and enforcement in China regarding the judgments of a court in any of these non-PRC jurisdictions in relation to any matters not subject
to a binding arbitration provision may be difficult or even impossible.
We may rely on dividends and other distributions
on equity paid by our PRC subsidiaries to fund any cash and financing requirements that we may have, and any limitation on the ability
of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business. Moreover,
the Chinese government may, at its discretion, impose restrictions on access to foreign currencies for current account transactions and
if this occurs in the future, we may not be able to pay dividends in foreign currencies to our shareholders.
We are a Cayman Islands holding company, and
we rely on dividends and other distributions on equity paid by our PRC subsidiaries for our cash and financing requirements, including
the funds necessary to pay dividends and other cash distributions to our shareholders and repay any debt that we may incur. The ability
of our PRC subsidiaries to distribute dividends is based upon their distributable earnings. Current PRC regulations permit our PRC subsidiaries
to pay dividends to their respective shareholders only out of their accumulated profits, if any, which is determined in accordance with
the PRC accounting standards and regulations. In addition, according to the PRC Company Law, each of our PRC subsidiaries, as a wholly
foreign-owned enterprise in China, is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory
reserve until the aggregate amount of such reserve reaches 50% of its registered capital. At its discretion, a wholly foreign-owned enterprise
may allocate a portion of its after-tax profits based on PRC accounting standards to staff welfare and bonus funds. These reserve funds
and staff welfare and bonus funds are not distributable as cash dividends. If our PRC subsidiaries incur debt on their own behalf in
the future, the instruments governing the debt may also restrict their ability to pay dividends or make other payments to us. Any limitation
on the ability of our PRC subsidiaries to distribute dividends or other payments to their respective shareholders could materially and
adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends or otherwise
fund and conduct our business.
Furthermore, under existing PRC foreign exchange
regulations, payments of current account items, including profit distributions, interest payments and expenditures from trade-related
transactions, can be made in foreign currencies without prior approval from SAFE as long as certain procedural requirements are met.
Approval from appropriate government authorities is required if RMB is converted into foreign currency and remitted out of China to pay
capital expenses such as the repayment of loans denominated in foreign currencies. The Chinese government may, at its discretion, impose
restrictions on access to foreign currencies for current account transactions and if this occurs in the future, we may not be able to
pay dividends in foreign currencies to our shareholders.
See “Item 3. Key Information — D.
Risk Factors — Risks Related to Doing Business in China — We may rely on dividends and other distributions on equity paid
by our PRC subsidiaries to fund any cash and financing requirements that we may have, and any limitation on the ability of our PRC subsidiaries
to make payments to us could have a material and adverse effect on our ability to conduct our business.” on page 41 of our
annual report on Form 20-F for the fiscal year ended December 31, 2022.
If the PCAOB is unable to inspect our auditors
as required under the Holding Foreign Companies Accountable Act, the SEC will prohibit the trading of our shares. A trading prohibition
for our shares, or the threat of a trading prohibition, may materially and adversely affect the value of your investment. Additionally,
the inability of the PCAOB to conduct inspections of our auditors, if any, would deprive our investors of the benefits of such inspections.
The Holding Foreign Companies Accountable Act
was enacted on December 18, 2020. The HFCA Act states if the SEC determines that we have filed audit reports issued by a registered
public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall
prohibit our shares from being traded on a national securities exchange or in the over-the-counter trading market in the U.S.
On March 24, 2021, the SEC adopted interim
final rules relating to the implementation of certain disclosure and documentation requirements of the HFCA Act. A company will
be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to
be subsequently established by the SEC. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies
Accountable Act. On December 29, 2022, the Accelerating Holding Foreign Companies Accountable Act was enacted, which amended the
HFCA Act, by requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not
subject to PCAOB inspections for two consecutive years instead of three.
On August 26, 2022, the PCAOB signed a Statement
of Protocol with the CSRC and Ministry of Finance, taking the first step toward opening access for the PCAOB to inspect and investigate
registered public accounting firms headquartered in mainland China and Hong Kong completely, consistent with U.S. law.
On December 15, 2022, the PCAOB announced
that it was able to conduct inspections and investigations completely of PCAOB-registered public accounting firms headquartered in mainland
China and Hong Kong in 2022. The PCAOB vacated its previous determinations issued in December 2021 accordingly. As a result, we
do not expect to be identified as a “Commission-Identified Issuer” under the HFCA Act for the fiscal year ended December 31,
2022 after we file our annual report on Form 20-F for such fiscal year. However, whether the PCAOB will continue to conduct inspections
and investigations completely to its satisfaction of PCAOB-registered public accounting firms headquartered in mainland China and Hong
Kong is subject to uncertainty and depends on a number of factors out of our, and our auditor’s, control, including positions taken
by authorities of the PRC. The PCAOB is expected to continue to demand complete access to inspections and investigations against accounting
firms headquartered in mainland China and Hong Kong in the future and states that it has already made plans to resume regular inspections
in early 2023 and beyond. The PCAOB is required under the HFCA Act to make its determination on an annual basis with regards to its ability
to inspect and investigate completely accounting firms based in the mainland China and Hong Kong. The possibility of being a “Commission-Identified
Issuer” and risk of delisting could continue to adversely affect the trading price of our securities. Should the PCAOB again encounter
impediments to inspections and investigations in mainland China or Hong Kong as a result of positions taken by any authority in either
jurisdiction, the PCAOB will make determinations under the HFCA Act as and when appropriate.
Our current auditor, Onestop, and our prior
auditor for the 2020 and 2021 annual reports, Marcum Asia, the independent registered public accounting firms that issued our financial
reports incorporated by reference in this prospectus or included in our most recent annual report on Form 20-F, are registered with the
PCAOB. The PCAOB conducts regular inspections to assess their compliance with the applicable professional standards. Onestop and Marcum
Asia are headquartered in Singapore and New York, respectively, and, as of the date of this prospectus, were not included in the list
of PCAOB Identified Firms in the PCAOB Determinations issued in December 2021.
Our ability to retain an auditor subject to
the PCAOB inspection and investigation, including but not limited to inspection of the audit working papers related to us, may depend
on the relevant positions of U.S. and Chinese regulators. Both Onestop and Marcum Asia’s audit working papers related to us are
located in China. With respect to audits of companies with operations in China, such as our Company, there are uncertainties about the
ability of the auditor to fully cooperate with a request by the PCAOB for audit working papers in China without the approval of Chinese
authorities.
Whether the PCAOB will be able to conduct inspections
of our auditor, including but not limited to inspection of the audit working papers related to us, in the future is subject to substantial
uncertainty and depends on a number of factors out of our, and our auditor’s, control. If our shares are prohibited from trading
in the United States, there is no certainty that we will be able to list on a non-U.S. exchange or that a market for our shares will
develop outside of the United States. Such a prohibition would substantially impair your ability to sell or purchase our shares when
you wish to do so, and the risk and uncertainty associated with delisting would have a negative impact on the price of our shares. Also,
such a prohibition would significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material
adverse impact on our business, financial condition, and prospects.
See “Item 3. Key Information — D.
Risk Factors — Risks Related to Doing Business in China — If the PCAOB is unable to inspect our auditors as required under
the Holding Foreign Companies Accountable Act, the SEC will prohibit the trading of our shares. A trading prohibition for our shares,
or the threat of a trading prohibition, may materially and adversely affect the value of your investment. Additionally, the inability
of the PCAOB to conduct inspections of our auditors, if any, would deprive our investors of the benefits of such inspections” on
page 48 to 49 of our annual report on Form 20-F for the fiscal year ended December 31, 2022.
OFFER STATISTICS AND EXPECTED TIMETABLE
We may from time to time, offer and sell any
combination of the securities described in this prospectus (as may be detailed in a prospectus supplement) up to a total dollar amount
of US$300,000,000 in one or more offerings. The selling securityholders may sell from time to time pursuant to this prospectus up to
149,569,964 ordinary shares (including 7,138,863 ordinary shares issuable upon exercise of the warrants and 50,000,000 Ordinary Shares
issuable upon the conversion of 50,000 convertible Series F Preferred Shares) and up to 7,138,863 warrants to purchase 7,138,863 of our
Ordinary Shares. The securities offered under this prospectus may be offered separately, together, or in separate series, and in amounts,
at prices, and on terms to be determined at the time of sale. See “Plan of Distribution.” We will keep the registration statement
of which this prospectus is a part effective until such time as all of the securities covered by this prospectus have been disposed of
pursuant to and in accordance with such registration statement.
CAPITALIZATION AND INDEBTEDNESS
Our capitalization will be set forth in the applicable
prospectus supplement or in a report on Form 6-K subsequently furnished to the SEC and specifically incorporated by reference into
this prospectus.
DILUTION
If required, we will set forth in a prospectus supplement the following
information regarding any material dilution of the equity interests of investors purchasing securities in an offering under this prospectus:
|
● |
the net tangible book value
per share of our equity securities before and after the offering; |
|
● |
the amount of the increase
in such net tangible book value per share attributable to the cash payments made by purchasers in the offering; and |
|
● |
the amount of the immediate
dilution from the public offering price which will be absorbed by such purchasers. |
USE OF PROCEEDS
We will retain broad discretion over the use
of the net proceeds from the sale of the securities offered hereby. Unless otherwise specified in any prospectus supplement, we currently
intend to use the net proceeds from the sale of our securities offered under this prospectus for general corporate purposes, which may
include capital expenditures, working capital, and other business opportunities.
We will not receive any proceeds from the sale
of any securities by the selling securityholders. The selling securityholders will receive all of the net proceeds from the sale of any
securities offered by them under this prospectus. The selling securityholders will bear any underwriting discounts and commission and
expenses incurred by them for brokerage, accounting, tax, legal services or any other expenses incurred by the selling securityholders
in disposing of these securities. We will bear all other costs, fees and expenses incurred in effecting the registration of the securities
covered by this prospectus.
DESCRIPTION OF SHARE CAPITAL
We are an exempted company incorporated under
the laws of the Cayman Islands and our affairs are governed by our third amended and restated memorandum and articles of association,
as amended and restated from time to time, and Companies Act (As Revised) of the Cayman Islands (the “Companies Act”), and
the common law of the Cayman Islands.
As of the date of this prospectus, our authorized
share capital was US$50,000 divided into (a) 999,926,000 ordinary shares of a par value of US$0.00005 each, (b) 6,000 Series A
convertible preferred shares of a par value of US$0.0001 each, (c) 6,000 Series D convertible preferred shares of a nominal
or par value of US$0.0001 each, and (d) 50,000 convertible Series F Preferred Shares of a nominal or par value of US$0.0005 each. As of
the date of this prospectus, there are 228,250,210 ordinary shares, no Series A convertible
preferred share, 6,000 Series D convertible preferred shares issued and outstanding, and 50,000 convertible Series F Preferred Shares
issued and outstanding.
Our Third Amended and Restated Memorandum
and Articles of Association
The following are summaries of material provisions
of our Third Amended and Restated Memorandum and Articles of Association and the Companies Act insofar as they relate to the material
terms of our ordinary shares and warrants.
Ordinary Shares
General.
Our ordinary shares are fully paid and non-assessable. Our ordinary shares are issued in registered form and are issued
when registered in our register of members.
Dividends.
The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors. In addition,
our shareholders may declare dividends by ordinary resolution, but no dividend shall exceed the amount recommended by our directors.
Our third amended and restated memorandum and articles of association provide that the directors may, before recommending or declaring
any dividends, set aside out of the funds legally available for distribution such sums as they think proper as a reserve or reserves
which shall, in the absolute discretion of the directors, be applicable for meeting contingencies or for equalizing dividends or for
any other purpose to which those funds may be properly applied. Under the laws of the Cayman Islands, our company may pay a dividend
out of either profit or share premium account, provided that in no circumstances may a dividend be paid if this would result in our company
being unable to pay its debts as they fall due in the ordinary course of business.
Voting
Rights. Each ordinary share shall be entitled to one vote on all matters subject to a vote at general meetings of our
company. Voting at any shareholders’ meeting is by show of hands unless a poll is demanded (before or on the declaration of the
result of the show of hands). A poll may be demanded by the chairman of such meeting or any one or more shareholders who together hold
not less than one tenth of the paid up voting share capital of the Company which are present in person or by proxy at the meeting.
An ordinary resolution to be passed at a meeting
by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast at a meeting,
while a special resolution requires the affirmative vote of no less than two-thirds of the votes cast attaching to the outstanding ordinary
shares at a meeting and includes a unanimous written resolution. A special resolution will be required for important matters such as
a change of name or making changes to our third amended and restated memorandum and articles of association. Holders of the ordinary
shares may, among other things, divide or combine their shares by ordinary resolution.
General
Meetings of Shareholders. As a Cayman Islands exempted company, we are not obliged by the Companies Act to
call shareholders’ annual general meetings. Our third amended and restated memorandum and articles of association provide that
we may (but are not obliged to) in each year hold a general meeting as our annual general meeting in which case we shall
specify the meeting as such in the notices calling it, and the annual general meeting shall be held at such time and place as may be
determined by our directors.
Shareholders’ general meetings may be convened
by any director. Advance notice of at least seven calendar days is required for the convening of our annual general shareholders’
meeting (if any) and any other general meeting of our shareholders. A quorum required for any general meeting of shareholders consists
of at least one shareholder present in person or by proxy, representing not less than an aggregate of one-third of all votes attaching
to all of our shares in issue and entitled to vote.
The Companies Act provides shareholders with
only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general
meeting. However, these rights may be provided in a company’s articles of association. Our third amended and restated memorandum
and articles of association provide that upon the requisition of shareholders representing in aggregate not less than one-fifth of the
votes attaching to the issued and outstanding shares of our company entitled to vote at general meetings, our board of directors will
convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. However, our third amended
and restated memorandum and articles of association do not provide our shareholders with any right to put any proposals before annual
general meetings or extraordinary general meetings not called by such shareholders.
Transfer
of Ordinary Shares. Subject to the restrictions contained in our third amended and restated articles of association, any
of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or
any other form approved by our board of directors.
Our board of directors may, in its absolute discretion,
decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors
may also decline to register any transfer of any ordinary share unless:
|
● |
the instrument of transfer
is lodged with our company, accompanied by the certificate for the shares to which it relates and such other evidence as the Board
may reasonably require to show the right of the transferor to make the transfer; |
|
● |
the shares to be transferred
are free of any lien in favor of our company; |
|
|
|
|
● |
the instrument of transfer
is in respect of only one class of shares; |
|
|
|
|
● |
the instrument of transfer
is properly stamped, if required; and |
|
● |
in case of a transfer to
joint holders, the number of joint holders to whom the Shares is to be transferred does not exceed four; a fee of such maximum sum
as the Nasdaq Capital Market may determine to be payable or such lesser sum as our directors may from time to time require, is paid
to our company in respect thereof. |
If our directors refuse to register a transfer,
they shall, within two months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee
notice of such refusal.
The registration of transfers may, on 14 days’
notice being given by advertisement in one or more newspapers or by electronic means, be suspended and the register closed at such times
and for such periods as our board of directors may from time to time determine.
Liquidation.
On the winding up of our company, if the assets available for distribution amongst our shareholders shall be insufficient
to repay the whole of the share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by
our shareholders in proportion to the par value of the shares held by them. If in a winding up the assets available for distribution
amongst our shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up,
the surplus shall be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement
of the winding up subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company
for unpaid calls or otherwise.
Calls
on Shares and Forfeiture of Shares. Our board of directors may from time to time make calls upon shareholders for any
amounts unpaid on their shares in a notice served to such shareholders at least 14 calendar days prior to the specified time of payment.
The ordinary shares that have been called upon and remain unpaid are subject to forfeiture.
Redemption,
Repurchase and Surrender of Shares. We may issue shares on terms that such shares are subject to redemption, at our option
or at the option of the holders of these shares, on such terms and in such manner as may be determined by our board of directors. Our
company may also repurchase any of our shares on such terms and in such manner as have been approved by our board of directors or by
an ordinary resolution of our shareholders (provided that no such purchase may be made contrary to the terms or manner recommended by
the board of directors). Under the Companies Act, the redemption or repurchase of any shares may be paid out of our company’s profits
or out of the proceeds of a new issuance of shares made for the purpose of such redemption or repurchase, or out of capital (including
share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall
due in the ordinary course of business. In addition, under the Companies Act no such shares may be redeemed or repurchased (a) unless
it is fully paid up; (b) if such redemption or repurchase would result in there being no shares outstanding; or (c) if the
company has commenced liquidation. In addition, our company may accept the surrender of any fully paid shares for no consideration.
Variations
of Rights of Shares. If at any time our share capital is divided into different classes or series of shares, the
rights attaching to any class or series (unless otherwise provided by the terms of issue of the shares of that class or series) may,
subject to our articles of association, be varied or abrogated with the consent in writing of the holders of a majority of the
issued shares of that class or series or with the sanction of a special resolution passed at a general meeting of the holders of the
shares of that class or series. The rights conferred upon the holders of the shares of any class or series issued with the preferred
or other rights shall not, unless otherwise expressly provided by the terms of issue of the shares of that class or series, be
deemed to be varied by the creation or issue of further shares ranking in priority thereto or pari passu therewith.
Issuance
of Additional Shares. Our third amended and restated memorandum and articles of association authorizes our board of directors
to issue additional ordinary shares from time to time as our board of directors shall determine, to the extent of available authorized
but unissued shares.
Our third amended and restated memorandum and
articles of association also authorizes our board of directors to establish from time to time one or more series of preference shares
and to determine, with respect to any series of preference shares, the terms and rights of that series, including:
|
● |
the
designation of the series; |
|
● |
the
number of shares of the series; |
|
● |
the
dividend rights, dividend rates, conversion rights, voting rights; and |
|
● |
the
rights and terms of redemption and liquidation preferences. |
Our board of directors may issue preferred shares
without action by our shareholders to the extent authorized but unissued. Issuance of these shares may dilute the voting power of holders
of the ordinary shares.
Inspection
of Books and Records. Holders of our ordinary shares will have no general rights under the Cayman Islands law to inspect
or obtain copies of our list of shareholders or our corporate records (except for the memorandum and articles of association, any special
resolutions passed by our shareholders and the register of mortgages and charges). However, we will provide our shareholders with annual
audited financial statements.
Anti-Takeover
Provisions. Some provisions of our third amended and restated memorandum and articles of association may discourage, delay
or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that:
|
● |
authorize our board of
directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions
of such preference shares without any further votes or actions by our shareholders; and |
|
● |
limit the ability of shareholders
to requisition and convene general meetings of shareholders. |
However, under Cayman Islands law, our directors
may only exercise the rights and powers granted to them under our third amended and restated memorandum and articles of association for
a proper purpose and for what they believe in good faith to be in the best interests of our company.
Changes
in Capital. We may from time to time by ordinary resolution:
|
● |
increase the share capital
by such sum, to be divided into shares of such amount, as the resolution shall prescribe; |
|
● |
consolidate and divide
all or any of the share capital into shares of a larger par value than the existing shares; |
|
● |
subdivide the existing
shares, or any of them into shares of a smaller par value than is fixed by our third amended and restated memorandum of association
(subject, nevertheless, to the Companies Act) provided that in the subdivision the proportion between the amount paid and
the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is
derived; or |
|
● |
cancel any shares which,
at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of
its share capital by the amount of the shares so cancelled. |
We may by special resolution, subject to any
confirmation or consent required by the Companies Act, reduce our share capital or any capital redemption reserve in any manner authorized
by law.
Indemnification
of Directors and Officers. Cayman Islands law does not limit the extent to which a company’s memorandum and articles
of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the
Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, willful neglect, civil
fraud or the consequences of committing a crime. Our third amended and restated memorandum and articles of association provides that
our directors and officers shall be indemnified and secured harmless against all actions, proceedings, costs, charges, expenses, losses,
damages or liabilities incurred or sustained by such Indemnified Person, other than by reason of such Indemnified Person's own dishonesty,
willful default or fraud, in or about the conduct of the Company's business or affairs (including as a result of any mistake of judgment)
or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of
the foregoing, any costs, expenses, losses or liabilities incurred by such Indemnified Person in defending (whether successfully or otherwise)
any civil proceedings concerning the Company or its affairs in any court whether in the Cayman Islands or elsewhere.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have
been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is
theretofore unenforceable.
Preferred Shares
Our third amended and restated memorandum and
articles of association provides that our board of directors may provide, out of the unissued shares, for series of preferred shares,
and before any preferred shares of any such series are issued, the board of directors shall fix, among other things, the designation
of such series, the number of preferred shares to constitute such series, the subscription price thereof, the dividends, if any, payable
on such series, voting rights, redemption rights, conversion rights, liquidation preferences and other rights of the holders of such
series.
Series A Convertible Preferred Shares
The number of shares designated as Series A
Convertible Preferred Shares shall be up to 6,000. Each Series A Convertible Preferred Share shall have a par value of $0.0001 per
share and a stated value equal to $1,000. Holders of our Series A Convertible Preferred Shares shall have the right to receive dividend
as required by the certificate of designation of Series A Convertible Preferred Shares. Our Series A Convertible Preferred
Shares have no voting rights. Each Series A Convertible Preferred Share shall be convertible, at the option of its holder, into
the number of ordinary shares of the Company equal to stated value divided by conversion price, which is $3.00 subject to adjustments.
No Series A Convertible Preferred Share shall be converted to ordinary shares if such conversion would result in the holder and
its affiliates together owning in excess of 4.99% of the outstanding ordinary shares, after giving effect to the shares issued upon conversion.
We have an option to redeem the Series A Convertible Preferred Shares by delivering a redemption notice to the holders at a price
of 115% of the stated value per Series A Convertible Preferred Share. In connection with any redemption notice, we shall issue to
the holders an ordinary share purchase warrant in the form of the Series a Warrant to purchase up to a number equal to 50% of the
principal amount of the Series A Convertible Preferred Shares subject to such optional redemption divided by the then conversion
price. As of the date of this prospectus, we have no Series A Convertible Preferred Shares issued and outstanding.
Series D Convertible Preferred Shares
The number of shares designated as Series D
Convertible Preferred Shares shall be up to 6,000. Each Series D Convertible Preferred Share shall have a par value of $0.0001 per
share and a stated value of $1,000. Holders of our Series D Convertible Preferred Shares shall have the right to receive dividend
as required by the certificate of designation of Series D Convertible Preferred Shares. Our Series D Convertible Preferred Shares
have no voting rights. Each Series D Convertible Preferred Share shall be convertible, at the option of its holder, into the number
ordinary shares of the Company equal to stated value divided by conversion price, which is $3.00 subject to customary anti-dilution adjustments.
We have an option, after March 30, 2022, to redeem the Series D Convertible Preferred Shares by delivering a redemption notice
to the holders at a price of 105% of the stated value per Series D Convertible Preferred Share. As of the date of this prospectus,
we have 6,000 Series D Convertible Preferred Shares issued and outstanding.
Series F Convertible Preferred Shares
The number of shares designated as Series F
Convertible Preferred Shares shall be up to 50,000. Each Series F Convertible Preferred Share shall have a par value of $0.00005
per share and a stated value of $1,000. Holders of our Series F Convertible Preferred Shares have no right to receive dividend. Our
Series F Convertible Preferred Shares have no voting rights. Each Series F Convertible Preferred Shares shall be convertible,
at the option of its holder, into the number of ordinary shares of the Company equal to stated value divided by conversion price, which
is $1.00. We have an option, after January 1, 2023, to redeem the Series F Convertible Preferred Shares by delivering a redemption
notice to the holders at a price of 105% of the stated value per Series F Convertible Preferred Share. As of the date of this prospectus,
we have 50,000 Series F Convertible Preferred Shares issued and outstanding.
Transfer Agent and Registrar
The transfer agent and registrar for our ordinary
shares in the United States is Transhare Corporation, with a mailing address of Bayside Center 1, 17755 US Highway 19 N, Suite 140,
Clearwater FL 33764
Listing
Our ordinary shares are listed on Nasdaq under
the symbol “KXIN”.
Differences in Corporate Law
The Companies Act is derived, to a large extent,
from the older Companies Acts of England, but does not follow many recent English law statutory enactments. In addition, the Companies
Act differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary of the significant
differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the State
of Delaware. This discussion does not purport to be a complete statement of the rights of our shareholders under applicable law in the
Cayman Islands and our third amended and restated memorandum and articles of association nor the rights of holders of the common stock
of a typical corporation under applicable Delaware law and a typical certificate of incorporation and bylaws.
Mergers
and Similar Arrangements. The Companies Act permits mergers and consolidations between Cayman Islands companies and
between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (a) “merger” means the
merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies
as the surviving company, and (b) a “consolidation” means the combination of two or more constituent companies into
a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company.
In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger
or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company,
and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. The
written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a
declaration as to the solvency of the consolidated or surviving company, a declaration as to the assets and liabilities of each
constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and
creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands
Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory
procedures.
A merger between a Cayman parent company and its
Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of
the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose,
a company is a “parent” of a subsidiary if it holds issued shares that together represent at least ninety percent (90%) of
the votes at a general meeting of the subsidiary.
The consent of each holder of a fixed or floating
security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands.
Save in certain limited circumstances, a shareholder
of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which,
if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to the merger or consolidation, provide
the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude
the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares,
save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful.
Separate from the statutory provisions relating
to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation
of companies by way of schemes of arrangement, provided that the arrangement is approved by (a) 75% in value of the shareholders
or class of shareholders, as the case may be, or (b) a majority in number representing 75% in value of the creditors or class of
creditors, as the case may be, with whom the arrangement is to be made that are, in each case, present and voting either in person or
by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be
sanctioned by the Grand Court of the Cayman Islands.
The Companies Act also contains a statutory power
of compulsory acquisition which may facilitate the “squeeze out” of a dissenting minority shareholder upon a tender offer.
When a tender offer is made and accepted by holders of 90.0% of the shares affected within four months, the offeror may, within a two-month
period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares to
the offeror on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed
in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.
If an arrangement and reconstruction is thus approved,
or if a tender offer is made and accepted, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise
ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially
determined value of the shares.
Shareholders’
Suits. In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general
rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all
likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law
principles (namely the rule in Foss v. Harbottle and the exceptions thereto) which permit a minority shareholder to commence a class
action against or derivative actions in the name of the company to challenge actions where:
|
● |
a company acts or proposes to act illegally or ultra vires; |
|
● |
the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and |
|
● |
those who control the company are perpetrating a “fraud on the minority.” |
Indemnification
of Directors and Executive Officers and Limitation of Liability. Cayman Islands law does not limit the extent to which
a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent
any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against
civil fraud or the consequences of committing a crime. Our third amended and restated memorandum and articles of association provides
that our officers and directors for the time being shall be indemnified and secured harmless against all actions, proceedings, costs,
charges, expenses, losses, damages or liabilities incurred or sustained by such Indemnified Person, other than by reason of such Indemnified
Person's own dishonesty, willful default or fraud, in or about the conduct of the Company's business or affairs (including as a result
of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice
to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such Indemnified Person in defending (whether
successfully or otherwise) any civil proceedings concerning the Company or its affairs in any court whether in the Cayman Islands or elsewhere.
This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
In addition, we have entered into indemnification
agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in
our third amended and restated memorandum and articles of association.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors, officers, or persons controlling us under the foregoing provisions, we have
been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is
therefore unenforceable.
Directors’
Fiduciary Duties. Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation
and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director
act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director
must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction.
The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He
must not use his corporate position for personal gain or advantage. This duty prohibits self- dealing by a director and mandates that
the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling
shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed
basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption
may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by
a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.
As a matter of Cayman Islands law, a director
of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes
the following duties to the company—a duty to act bona fide in the best interests of the company, a duty not to make a profit based
on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of
the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which
such powers were intended. A director of a Cayman Islands company owes to the company a duty to act with skill and care. It was previously
considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected
from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with
regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands.
Shareholder
Action by Written Consent. Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders
to act by written consent by amendment to its certificate of incorporation. The Companies Act provides that the shareholders may approve
corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to
vote on such matter at a general meeting without a meeting being held. Our third amended and restated memorandum and articles of association
provides that a resolution (including a special resolution) in writing (in one or more counterparts) signed by or on behalf of all of
the shareholders for the time being entitled to receive notice of and to attend and vote at general meetings (or, in the case of corporations
or other non-natural persons, signed by their duly authorized representatives) shall be as valid and effective as if the resolution had
been passed at a general meeting of our company duly convened and held.
Shareholder
Proposals. Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual
meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by
the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling
special meetings.
The Companies Act provides shareholders with only limited rights to
requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However,
these rights may be provided in a company’s articles of association. Our third amended and restated memorandum and articles of association
allows our shareholders holding in aggregate not less than one-fifth of all votes attaching to the issued and outstanding shares of our
company entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board
is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than
this right to requisition a shareholders’ meeting, our third amended and restated memorandum and articles of association does not
provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings not called
by such shareholders. As an exempted Cayman Islands company, we are not obliged by law to call shareholders’ annual general meetings.
Cumulative
Voting. Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless
the corporation’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation
of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder
is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. There are
no prohibitions in relation to cumulative voting under the laws of the Cayman Islands but our third amended and restated memorandum and
articles of association does not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or
rights on this issue than shareholders of a Delaware corporation.
Removal
of Directors. Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed
only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides
otherwise. Under our third amended and restated memorandum and articles of association, directors may be removed with or without cause,
by a special resolution of our shareholders. A director shall hold office until the expiration of his or her term or his or her successor
shall have been elected and qualified, or until his or her office is otherwise vacated. In addition, a director’s office shall be
vacated if the director (i) dies, becomes bankrupt or makes any arrangement or composition with his creditors; (ii) is found
to be or becomes of unsound mind; (iii) resigns his office by notice in writing to the company or tendered at a meeting of the board
of directors; (iv) without special leave of absence from our board of directors, is absent from three consecutive meetings of the
board and the board resolves that his office be vacated; or (v) is removed from office pursuant to any other provisions of our third
amended and restated memorandum and articles of association.
Transactions
with Interested Shareholders. The Delaware General Corporation Law contains a business combination statute applicable
to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to
its certificate of incorporation, it is prohibited from engaging in certain business combinations with an “interested
shareholder” for three years following the date that such person becomes an interested shareholder. An interested shareholder
generally is a person or a group who or which owns or owned 15% or more of the target’s outstanding voting share within the
past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in
which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which
such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the
transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware
corporation to negotiate the terms of any acquisition transaction with the target’s board of directors.
Cayman Islands law has no comparable statute.
As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although
Cayman Islands law does not regulate transactions between a company and its significant shareholders, the directors of the Company are
required to comply with fiduciary duties which they owe to the Company under Cayman Islands laws, including the duty to ensure that, in
their opinion, any such transactions must be entered into bona fide in the best interests of the company, and are entered into for a proper
corporate purpose and not with the effect of constituting a fraud on the minority shareholders.
Dissolution;
Winding up. Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve,
dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated
by the board of directors may it be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a
Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions
initiated by the board.
Under Cayman Islands law, a company may be wound up by either an order
of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall
due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including
where it is, in the opinion of the court, just and equitable to do so. Under the Companies Act and our third amended and restated memorandum
and articles of association, our company may be dissolved, liquidated or wound up by a special resolution of our shareholders.
Variation
of Rights of Shares. Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares
with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under
Cayman Islands law and our third amended and restated articles of association, if our share capital is divided into more than one class
of shares, we may vary the rights attached to any class with the written consent of the holders of a majority of the issued shares of
that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.
Amendment
of Governing Documents. Under the Delaware General Corporation Law, a corporation’s governing documents may be amended
with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.
Under the Companies Act and our third amended and restated memorandum and articles of association, our third amended and restated memorandum
and articles of association may only be amended by a special resolution of our shareholders.
Rights
of Nonresident or Foreign Shareholders. There are no limitations imposed by our third amended and restated memorandum and
articles of association on the rights of nonresident or foreign shareholders to hold or exercise voting rights on our shares. In addition,
there are no provisions in our third amended and restated memorandum and articles of association governing the ownership threshold above
which shareholder ownership must be disclosed.
DESCRIPTION OF ORDINARY
SHARES
We may issue our ordinary
shares either alone or underlying other securities convertible into or exercisable or exchangeable for our ordinary shares.
Holders of our ordinary
shares are entitled to certain rights and subject to certain conditions as set forth in our third amended and restated memorandum and
articles of association and the Companies Act. See “Description of Share Capital.”
DESCRIPTION OF OUR
PREFERRED SHARES
Our board of directors
has the authority, without action by our shareholders, to issue preferred shares in one or more series out of our authorized but unissued
share capital. Our board of directors may establish the number of shares to be included in each such series and may set the designations,
preferences, powers and other rights of the shares of a series of preferred shares. Accordingly, our board of directors is empowered,
without shareholder approval, to issue preferred shares with dividend, liquidation, conversion, redemption, voting or other rights which
could adversely affect the voting power or other rights of the holders of ordinary shares. The preferred shares could be utilized as a
method of discouraging, delaying or preventing a change in control of Kaixin Auto Holdings. The material terms of any series of preferred
shares that we offer, together with any material U.S. federal income tax considerations relating to such preferred shares, will be described
in a prospectus supplement.
Holders of our preferred
shares are entitled to certain rights and subject to certain conditions as set forth in our third amended and restated memorandum and
articles of association and the Companies Act. As of the date of this prospectus, we have 6,000 authorized Series A Convertible Preferred
Shares, among which 0 are issued and outstanding, 6,000 authorized, issued and outstanding Series D Convertible Preferred Shares,
and 50,000 authorized, issued and outstanding Series F Convertible Preferred Shares. For details, see “Description of Share
Capital.”
DESCRIPTION OF DEBT SECURITIES
General
We may issue debt securities which may or may
not be converted into our ordinary shares or preferred shares. We may issue the debt securities independently or together with any underlying
securities, and debt securities may be attached or separate from the underlying securities. In connection with the issuance of any debt
securities, we do not intend to issue them pursuant to a trust indenture upon reliance of Section 304(a)(8) of the Trust Indenture
Act and Rule 4a-1 promulgated thereunder.
The following description is a summary of selected
provisions relating to the debt securities that we may issue. The summary is not complete. When debt securities are offered in the future,
a prospectus supplement, information incorporated by reference, or a free writing prospectus, as applicable, will explain the particular
terms of those securities and the extent to which these general provisions may apply. The specific terms of the debt securities as described
in a prospectus supplement, information incorporated by reference, or free writing prospectus will supplement and, if applicable, may
modify or replace the general terms described in this section.
This summary and any description of debt securities
in the applicable prospectus supplement, information incorporated by reference, or free writing prospectus is subject to and is qualified
in its entirety by reference to all the provisions of any specific debt securities document or agreement. We will file each of these documents,
as applicable, with the SEC and incorporate them by reference as an exhibit to the registration statement of which this prospectus is
a part on or before the time we issue a series of warrants. See “Where You Can Find Additional Information” and “Incorporation
of Documents by Reference” below for information on how to obtain a copy of a debt securities document when it is filed.
When we refer to a series of debt securities,
we mean all debt securities issued as part of the same series under the applicable indenture.
Terms
The applicable prospectus supplement, information
incorporated by reference, or free writing prospectus, may describe the terms of any debt securities that we may offer, including, but
not limited to, the following:
|
● |
the title of the debt securities; |
|
● |
the total amount of the debt securities; |
|
● |
the amount or amounts of the debt securities will be issued and interest rate; |
|
● |
the conversion price at which the debt securities may be converted; |
|
● |
the date on which the right to convert the debt securities will commence and the date on which the right will expire; |
|
● |
if applicable, the minimum or maximum amount of debt securities that may be converted at any one time; |
|
● |
if applicable, a discussion of material federal income tax consideration; |
|
● |
if applicable, the terms of the payoff of the debt securities; |
|
● |
the identity of the indenture agent, if any; |
|
● |
the procedures and conditions relating to the conversion of the debt securities; and |
|
● |
any other terms of the debt securities, including terms, procedure and limitation relating to the exchange or conversion of the debt securities. |
Form, Exchange, and Transfer
We may issue the debt securities in registered
form or bearer form. Debt securities issued in registered form, i.e., book-entry form, will be represented by a global security registered
in the name of a depository, which will be the holder of all the debt securities represented by the global security. Those investors who
own beneficial interests in global debt securities will do so through participants in the depository’s system, and the rights of
these indirect owners will be governed solely by the applicable procedures of the depository and its participants. In addition, we may
issue debt securities in non-global form, i.e., bearer form. If any debt securities are issued in non-global form, debt securities certificates
may be exchanged for new debt securities certificates of different denominations, and holders may exchange, transfer, or convert their
debt securities at the debt securities agent’s office or any other office indicated in the applicable prospectus supplement, information
incorporated by reference or free writing prospectus.
Prior to the conversion of their debt securities,
holders of debt securities convertible for ordinary shares or preferred shares will not have any rights of holders of ordinary shares
or preferred shares, and will not be entitled to dividend payments, if any, or voting rights of the ordinary shares or preferred shares.
Conversion of Debt Securities
A debt security may entitle the holder to purchase,
in exchange for the extinguishment of debt, an amount of securities at a conversion price that will be stated in the debt security. Debt
securities may be converted at any time up to the close of business on the expiration date set forth in the terms of such debt security.
After the close of business on the expiration date, debt securities not exercised will be paid in accordance with their terms.
Debt securities may be converted as set forth
in the applicable offering material. Upon receipt of a notice of conversion properly completed and duly executed at the corporate trust
office of the indenture agent, if any, or to us, we will forward, as soon as practicable, the securities purchasable upon such exercise.
If less than all of the debt security represented by such security is converted, a new debt security will be issued for the remaining
debt security.
DESCRIPTION OF WARRANTS
General
We may issue warrants to purchase our securities.
We may issue the warrants independently or together with any underlying securities, and the warrants may be attached or separate from
the underlying securities. We may also issue a series of warrants under a separate warrant agreement to be entered into between us and
a warrant agent. The warrant agent will act solely as our agent in connection with the warrants of such series and will not assume any
obligation or relationship of agency for or with holders or beneficial owners of warrants.
The following description is a summary of selected
provisions relating to the warrants that we may issue. The summary is not complete. When warrants are offered in the future, a prospectus
supplement, information incorporated by reference, or a free writing prospectus, as applicable, will explain the particular terms of those
securities and the extent to which these general provisions may apply. The specific terms of the warrants as described in a prospectus
supplement, information incorporated by reference, or free writing prospectus will supplement and, if applicable, may modify or replace
the general terms described in this section.
This summary and any description of warrants in
the applicable prospectus supplement, information incorporated by reference, or free writing prospectus is subject to and is qualified
in its entirety by reference to all the provisions of any specific warrant document or agreement, if applicable. We will file each of
these documents, as applicable, with the SEC and incorporate them by reference as an exhibit to the registration statement of which this
prospectus is a part on or before the time we issue a series of warrants. See “Where You Can Find Additional Information”
and “Incorporation of Documents by Reference” below for information on how to obtain a copy of a warrant document when it
is filed.
When we refer to a series of warrants, we mean
all warrants issued as part of the same series under the applicable warrant agreement.
Terms
The applicable prospectus supplement, information
incorporated by reference, or free writing prospectus, may describe the terms of any warrants that we may offer, including, but not limited
to, the following:
|
● |
the title of the warrants; |
|
● |
the total number of warrants; |
|
● |
the price or prices at which the warrants will be issued; |
|
● |
the price or prices at which the warrants may be exercised; |
|
● |
the currency or currencies that investors may use to pay for the warrants; |
|
● |
the date on which the right to exercise the warrants will commence and the date on which the right will expire; |
|
● |
whether the warrants will be issued in registered form or bearer form; |
|
● |
information with respect to book-entry procedures, if any; |
|
● |
if applicable, the minimum or maximum amount of warrants that may be exercised at any one time; |
|
● |
if applicable, the designation and terms of the underlying securities with which the warrants are issued and the number of warrants issued with each underlying security; |
|
● |
if applicable, the date on and after which the warrants and the related underlying securities will be separately transferable; |
|
● |
if applicable, a discussion of material federal income tax considerations; |
|
● |
if applicable, the terms of redemption of the warrants; |
|
● |
the identity of the warrant agent, if any; |
|
● |
the procedures and conditions relating to the exercise of the warrants; and |
|
● |
any other terms of the warrants, including terms, procedures, and limitations relating to the exchange and exercise of the warrants. |
Warrant Agreement
We may issue the warrants in one or more series
under one or more warrant agreements, each to be entered into between us and a bank, trust company, or other financial institution as
warrant agent. We may add, replace, or terminate warrant agents from time to time. We may also choose to act as our own warrant agent
or may choose one of our subsidiaries to do so.
The warrant agent under a warrant agreement will
act solely as our agent in connection with the warrants issued under that agreement. Any holder of warrants may, without the consent of
any other person, enforce by appropriate legal action, on its own behalf, its right to exercise those warrants in accordance with their
terms.
Form, Exchange, and Transfer
We may issue the warrants in registered form or
bearer form. Warrants issued in registered form, i.e., book-entry form, will be represented by a global security registered in the name
of a depository, which will be the holder of all the warrants represented by the global security. Those investors who own beneficial interests
in a global warrant will do so through participants in the depository’s system, and the rights of these indirect owners will be
governed solely by the applicable procedures of the depository and its participants. In addition, we may issue warrants in non-global
form, i.e., bearer form. If any warrants are issued in non-global form, warrant certificates may be exchanged for new warrant certificates
of different denominations, and holders may exchange, transfer, or exercise their warrants at the warrant agent’s office or any
other office indicated in the applicable prospectus supplement, information incorporated by reference, or free writing prospectus.
Prior to the exercise of their warrants, holders
of warrants exercisable for ordinary shares or preferred shares will not have any rights of holders of ordinary shares or preferred shares
and will not be entitled to dividend payments, if any, or voting rights of the ordinary shares or preferred shares.
Exercise of Warrants
A warrant will entitle the holder to purchase
for cash an amount of securities at an exercise price that will be stated in, or that will be determinable as described in, the applicable
prospectus supplement, information incorporated by reference, or free writing prospectus. Warrants may be exercised at any time up to
the close of business on the expiration date set forth in the applicable offering material. After the close of business on the expiration
date, unexercised warrants will become void. Warrants may be redeemed as set forth in the applicable offering material.
Warrants may be exercised as set forth in the
applicable offering material. Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate
trust office of the warrant agent or any other office indicated in the applicable offering material, we will forward, as soon as practicable,
the securities purchasable upon such exercise. If less than all of the warrants represented by such warrant certificate are exercised,
a new warrant certificate will be issued for the remaining warrants.
Outstanding Warrants
As of the date of this prospectus, we have 23,395,062
warrants outstanding, which consist of 11,318,145 public warrants, 375,000 warrants included in units issued to E&A Callet Investment
Limited (“E&A Callet”), 263,863 warrants held by Shareholder Value Fund, the sponsor of the initial public offering of
CM Seven Star, underlying the units sold to Shareholder Value Fund through a private placement, 1,532,500 Series A Convertible Warrants,
1,362,221 Series B Convertible Warrants, and 2,043,333 Series C Convertible Warrants, and 6,500,000 Series D Convertible Warrants.
Public Warrants
As of the date of this prospectus, we have 11,318,145
public warrants outstanding(“Public Warrants”). Each Public Warrant is exercisable for one ordinary share at a price of $11.50
per full share. Public Warrants may only be exercised for whole numbers of shares. The Public Warrants became exercisable on April 30,
2019, the date the Business Combination was consummated. The warrants shall terminate on the earlier of (i) five years of the completion
of the Business Combination, or (ii) the date on which the Public Warrants are fully redeemed by us.
During any period we fail to maintain effective
registration statement, holders of Public Warrants may exercise the Public Warrants on a cashless basis pursuant to an available exemption
from registration under the Securities Act. In such event, each holder would pay the exercise price by surrendering the Public Warrants
for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying
the Public Warrants, multiplied by the difference between the exercise price of the Public Warrants and the “fair market value”
(defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price
of the ordinary shares for the 10 trading days ending on the day prior to the date of exercise.
We may redeem the outstanding Public Warrants,
in whole and not in part, at a price of $0.01 per warrant:
|
· |
at any time while the Public Warrants are exercisable, |
|
· |
upon a minimum of 30 days’ prior written notice of redemption, |
|
· |
if, and only if, the last sales price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30 trading day period ending three business days before the Company sends the notice for redemption; and |
|
· |
if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. |
If we call the Public warrants for redemption
as described above, the management will have the option to require all holders that wish to exercise the Public Warrants to do so on a
“cashless basis.”
Private Warrants
As of the date of this prospectus, there are 638,863
private warrants outstanding, expiring on the earlier of (i) five years of the completion of the Business Combination, or (ii) the
date on which the Public Warrants are fully redeemed by us, each exercisable to purchase one ordinary share at a price of $11.50 per full
share. The private warrants include (i) 375,000 private warrants underlying the 750,000 units purchased by E&A Callet through
a subscription agreement dated January 29, 2019 warrants were issued to E&A Callet and (ii) 263,863 warrants held by Shareholder
Value Fund, the sponsor of the initial public offering of CM Seven Star, underlying the units sold to Shareholder Value Fund through a
private placement.
The Private Warrants have the same terms and conditions
as the Public Warrants.
Series A Convertible Warrants
As of the date of this prospectus, there are 1,532,500
Series A Convertible Warrants outstanding, expiring on December 29, 2027, each exercisable to purchase one ordinary share at
a price of $3.00 per full share, subject to adjustments. We will not issue fractional shares.
The following is a brief summary of certain terms
and conditions of the Series A Convertible Warrants and is subject in all respect to the provisions contained in the Series A
Convertible Warrants and the Securities Purchase Agreement entered into by and between our Company and KX Venturas 4 LLC, dated December 28,
2020 (the “Securities Purchase Agreement”).
Term.
The Series A Convertible Warrants are exercisable on the date of issuance and will expire on the seventh anniversary of the date
of issuance.
Exercisability.
The Series A Convertible Warrants are exercisable, at the option of the holder, in whole or in part by delivering to us a duly executed
exercise notice and payment in full for the number of ordinary shares purchased upon such exercise, except in the case of a cashless exercise
as discussed below. The number of ordinary shares issuable upon exercise of the Series A Convertible Warrants is subject to adjustments
in certain circumstances, including a stock split of, stock dividend on, or a subdivision, combination or recapitalization of the ordinary
shares. If we effect a merger, consolidation, sale of substantially all of our assets, or other similar transaction, then, upon any subsequent
exercise of a Series A Convertible Warrant, the Series A Convertible Warrant holder will have the right to receive any shares
of the acquiring corporation or other consideration it would have been entitled to receive if it had been a holder of the number of ordinary
shares then issuable upon exercise in full of the Series A Convertible Warrants.
Exercise
Price. The exercise price of the Series A Convertible Warrants is $3.00 per full ordinary share. The exercise
price is subject to anti-dilution adjustments. For instance, in the event that we conduct subsequent equity sales at an effective price
less than the exercise price then in effect, then at the consummation of the sales the exercise price shall be reduced to equal to the
effective price. The exercise price is also subject to adjustments in the event of a fundamental transaction including a merger, consolidation,
sale of substantially all of our assets, or other similar transaction. Subject to limited exceptions, the holder of Series A Convertible
Warrants will not have the right to exercise any portion of the Series A Convertible Warrants to the extent that, after giving effect
to the exercise, the holder, together with its affiliates, and any other person acting as a group together with the holder or any of its
affiliates, would beneficially own in excess of 4.9% of the number of ordinary shares outstanding immediately after giving effect to its
exercise. The holder, upon notice to the Company, may increase or decrease the beneficial ownership limitation provisions of the Series A
Convertible Warrants, provided that in no event shall the limitation exceed 9.99% of the number of ordinary shares outstanding immediately
after giving effect to the exercise of the Series A Convertible Warrants.
Cashless
Exercise. If we fail to maintain the effectiveness of the registration statement and current prospectus relating
to the ordinary shares issuable upon exercise of the Series A Convertible Warrants, the holder shall have the right to exercise the
Series A Convertible Warrants solely via a cashless exercise feature provided for in the Series A Convertible Warrants, until
such time as there is an effective registration statement and current prospectus. Upon a cashless exercise, the holder would be entitled
to receive a number of ordinary shares in accordance with certain formula set forth in the Series A Convertible Warrants.
Delivery
of ordinary shares. We shall deliver the ordinary shares underlying the Series A Convertible Warrants to the
holder exercising such warrants no later than the earlier of (i) two trading days following the exercise date, or (ii) one trading
day after delivery of the payment of exercise price by the holder to us.
No
Fractional Shares. No fractional shares or script representing fractional shares shall be issued upon the exercise
of the Series A Convertible Warrants, and the number of the Series A Convertible Warrants will be rounded to the nearest whole
number.
Transferability.
Subject to applicable laws and restrictions, the holder may transfer, in whole or in part, the Series A Convertible Warrants
upon surrender of the Series A Convertible Warrants to us with a completed and signed assignment in the form attached to the Series A
Convertible Warrants.
Authorized
Shares. During the period the Series A Convertible Warrants are outstanding, we will reserve from our authorized
and unissued ordinary shares a sufficient number of shares to provide for the issuance of ordinary shares underlying the Series A
Convertible Warrants upon exercise.
Fundamental
Transactions. In the event of any fundamental transaction, generally including any merger with or into another
entity, sale of all or substantially all of our assets, tender offer or exchange offer, reclassification of our ordinary shares or
the consummation of a transaction whereby more than 50% of our outstanding voting power, then the holder shall have the right to
receive for each ordinary share that would have been issuable upon such exercise immediately prior to the occurrence of such
fundamental transaction, the number of ordinary shares of the successor or acquiring corporation and any additional consideration
receivable upon or as a result of such transaction by a holder of the number of ordinary shares for which the Series A
Convertible Warrants is exercisable immediately prior to such event.
Waivers
and Amendments. Any term of the Series A Convertible Warrants issued may be amended or waived with the written consent
of us and the holder of the Series A Convertible Warrants.
Series B Convertible Warrants
As of the date of this prospectus, we have 1,362,221
Series B Convertible Warrants outstanding, expiring on August 29, 2024, each exercisable to purchase one ordinary share at a
price of $3.00 per full share, subject to adjustments. We will not issue fractional shares.
Other than the expiration date, our Series B
Convertible Warrants have the same terms and conditions as our Series A Convertible Warrants.
Series C Convertible Warrants
As of the date of this prospectus, we have 2,043,333
Series C Convertible Warrants outstanding, expiring on June 29, 2028, each exercisable to purchase one ordinary share at a price
of $3.00 per full share, subject to adjustments. We will not issue fractional shares.
The exercisability of our Series C Convertible
Warrants shall vest ratably from time to time in proportion to the holder’s exercise of the Series B Convertible Warrants as
compared with all Series B Convertible Warrants issued to the holder, subject to the vesting schedule in the Series C Convertible
Warrants.
Other than the vesting requirement and the expiration
date, our Series C Convertible Warrants have the same terms and conditions as our Series A Convertible Warrants.
Series D Convertible Warrants
As of the date of this prospectus, we have 6,500,000
Series D Convertible Warrants outstanding, expiring on December 31, 2025, each exercisable to purchase one ordinary share at
a price of $1.00 per full share, subject to adjustments. We will not issue fractional shares.
Other than the expiration date and exercise price,
our Series D Convertible Warrants have the same terms and conditions as our Series A Convertible Warrants.
DESCRIPTION OF RIGHTS
We may issue rights to purchase our securities.
The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights offering, we
may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters
or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series of rights will
be issued under a separate rights agent agreement to be entered into between us and one or more banks, trust companies, or other financial
institutions, as rights agent, which we will name in the applicable prospectus supplement. The rights agent will act solely as our agent
in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any holders of rights
certificates or beneficial owners of rights.
The prospectus supplement relating to any rights
that we offer will include specific terms relating to the offering, including, among other matters:
|
● |
the date of determining the security holders entitled to the rights distribution; |
|
● |
the aggregate number of rights issued and the aggregate amount of securities purchasable upon exercise of the rights; |
|
● |
the conditions to completion of the rights offering; |
|
● |
the date on which the right to exercise the rights will commence and the date on which the rights will expire; and |
|
● |
any applicable federal income tax considerations. |
Each right would entitle the holder of the rights
to purchase for cash the principal amount of securities at the exercise price set forth in the applicable prospectus supplement. Rights
may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement.
After the close of business on the expiration date, all unexercised rights will become void.
If less than all of the rights issued in any rights
offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders, to or through agents,
underwriters, or dealers, or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable
prospectus supplement.
DESCRIPTION OF UNITS
We may issue units composed of any combination
of our securities. We will issue each unit so that the holder of the unit is also the holder of each security included in the unit. As
a result, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which
a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any
time before a specified date.
The following description is a summary of selected
provisions relating to units that we may offer. The summary is not complete. When units are offered in the future, a prospectus supplement,
information incorporated by reference, or a free writing prospectus, as applicable, will explain the particular terms of those securities
and the extent to which these general provisions may apply. The specific terms of the units as described in a prospectus supplement, information
incorporated by reference, or free writing prospectus will supplement and, if applicable, may modify or replace the general terms described
in this section.
This summary and any description of units in the
applicable prospectus supplement, information incorporated by reference, or free writing prospectus is subject to and is qualified in
its entirety by reference to the unit agreement, collateral arrangements, and depositary arrangements, if applicable. We will file each
of these documents, as applicable, with the SEC and incorporate them by reference as an exhibit to the registration statement of which
this prospectus is a part on or before the time we issue a series of units. See “Where You Can Find Additional Information”
and “Incorporation of Documents by Reference” below for information on how to obtain a copy of a document when it is filed.
The applicable prospectus supplement, information
incorporated by reference, or free writing prospectus may describe:
|
● |
The designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; |
|
● |
Any provisions for the issuance, payment, settlement, transfer, or exchange of the units or of the securities composing the units; |
|
● |
Whether the units will be issued in fully registered or global form; and |
|
● |
Any other terms of the units. |
The applicable provisions described in this section,
as well as those described under “Description of Share Capital,” “Description of American Depositary Shares,”
“Description of Debt Securities,” “Description of Warrants,” and “Description of Rights” above, will
apply to each unit and to each security included in each unit, respectively.
PLAN OF DISTRIBUTION
We may sell the securities offered by this prospectus
from time to time in one or more transactions, including, without limitation:
|
● |
to or through underwriters; |
|
● |
through broker-dealers (acting as agent or principal); |
|
● |
directly by us to purchasers (including our affiliates and shareholders), through a specific bidding or auction process, a rights offering, or other method; |
|
● |
through a combination of any such methods of sale; or |
|
● |
through any other methods described in a prospectus supplement. |
The distribution of securities may be effected,
from time to time, in one or more transactions, including:
|
● |
block transactions (which may involve crosses) and transactions on Nasdaq or any other organized market where the securities may be traded; |
|
● |
purchases by a broker-dealer as principal and resale by the broker-dealer for its own account pursuant to a prospectus supplement; |
|
● |
ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers; |
|
● |
sales “at the market” to or through a market maker or into an existing trading market, on an exchange or otherwise; and |
|
● |
sales in other ways not involving market makers or established trading markets, including direct sales to purchasers. |
The securities may be sold at a fixed price
or prices, which may be changed, or at market prices prevailing at the time of sale, at prices relating to the prevailing market
prices or at negotiated prices. The consideration may be cash, extinguishment of debt, or another form negotiated by the parties.
Agents, underwriters, or broker-dealers may be paid compensation for offering and selling the securities. That compensation may be
in the form of discounts, concessions, or commissions to be received from us or from the purchasers of the securities. Dealers and
agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them on
resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. If such dealers or
agents were deemed to be underwriters, they may be subject to statutory liabilities under the Securities Act.
We may also make direct sales through subscription
rights distributed to our existing shareholders on a pro rata basis, which may or may not be transferable. In any distribution of subscription
rights to our shareholders, if all of the underlying securities are not subscribed for, we may then sell the unsubscribed securities directly
to third parties or may engage the services of one or more underwriters, dealers, or agents, including standby underwriters, to sell the
unsubscribed securities to third parties.
Some or all of the securities that we offer through
this prospectus may be new issues of securities with no established trading market. Any underwriters to whom we sell our securities for
public offering and sale may make a market in those securities, but they will not be obligated to do so and they may discontinue any market
making at any time without notice. Accordingly, we cannot assure you of the liquidity of, or continued trading markets for, any securities
that we offer.
Agents may, from time to time, solicit offers to purchase the securities.
If required, we will name in the applicable prospectus supplement, document incorporated by reference, or free writing prospectus, as
applicable, any agent involved in the offer or sale of the securities and set forth any compensation payable to the agent. Unless otherwise
indicated, any agent will be acting on a best efforts basis for the period of its appointment. Any agent selling the securities covered
by this prospectus may be deemed to be an underwriter of the securities.
If underwriters are used in an offering, securities
will be acquired by the underwriters for their own account and may be resold, from time to time, in one or more transactions, including
negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale, or under delayed delivery
contracts or other contractual commitments. Securities may be offered to the public either through underwriting syndicates represented
by one or more managing underwriters or directly by one or more firms acting as underwriters. If an underwriter or underwriters are used
in the sale of securities, an underwriting agreement will be executed with the underwriter or underwriters at the time an agreement for
the sale is reached. The applicable prospectus supplement will set forth the managing underwriter or underwriters, as well as any other
underwriter or underwriters, with respect to a particular underwritten offering of securities, and will set forth the terms of the transactions,
including compensation of the underwriters and dealers and the public offering price, if applicable. This prospectus, the applicable prospectus
supplement and any applicable free writing prospectus will be used by the underwriters to resell the securities.
If a dealer is used in the sale of the securities,
we, or an underwriter, will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at
varying prices to be determined by the dealer at the time of resale. To the extent required, we will set forth in the prospectus supplement,
document incorporated by reference, or free writing prospectus, as applicable, the name of the dealer and the terms of the transactions.
We may directly solicit offers to purchase the
securities and may make sales of securities directly to institutional investors or others. These persons may be deemed to be underwriters
with respect to any resale of the securities. To the extent required, the prospectus supplement, document incorporated by reference, or
free writing prospectus, as applicable, will describe the terms of any such sales, including the terms of any bidding or auction process,
if used.
Agents, underwriters, and dealers may be entitled
under agreements which may be entered into with us to indemnification by us against specified liabilities, including liabilities incurred
under the Securities Act, or to contribution by us to payments they may be required to make in respect of such liabilities. If required,
the prospectus supplement, document incorporated by reference, or free writing prospectus, as applicable, will describe the terms and
conditions of such indemnification or contribution. Some of the agents, underwriters, or dealers, or their affiliates may be customers
of, engage in transactions with or perform services for us or our subsidiaries or affiliates in the ordinary course of business.
Under the securities laws of some states, the
securities offered by this prospectus may be sold in those states only through registered or licensed brokers or dealers.
Any person participating in the distribution of
securities registered under the registration statement that includes this prospectus will be subject to applicable provisions of the Exchange
Act, and the applicable SEC rules and regulations, including, among others, Regulation M, which may limit the timing of purchases
and sales of any of our securities by any such person. Furthermore, Regulation M may restrict the ability of any person engaged in the
distribution of our securities to engage in market-making activities with respect to our securities.
These restrictions may affect the marketability
of our securities and the ability of any person or entity to engage in market-making activities with respect to our securities.
Certain persons participating in an offering may
engage in over-allotment, stabilizing transactions, short-covering transactions, and penalty bids in accordance with Regulation M under
the Exchange Act that stabilize, maintain, or otherwise affect the price of the offered securities. If any such activities will occur,
they will be described in the applicable prospectus supplement.
To the extent required, this prospectus may be
amended or supplemented from time to time to describe a specific plan of distribution.
SELLING SECURITYHOLDERS
This prospectus covers the public resale of
our securities owned by the selling securityholders named below. Such selling securityholders may from time to time offer and sell
pursuant to this prospectus any or all of the ordinary shares and/or warrants owned by them. The selling securityholders, however,
make no representations that the ordinary shares or warrants will be offered for sale. The table below presents information
regarding the selling securityholders and the ordinary shares and/or warrants that each may offer and sell from time to time under
this prospectus.
The following table sets forth:
·
the name of each selling securityholder;
· the number of securities beneficially
owned by each selling securityholder prior to the sale of the securities covered by this prospectus;
· the number of securities that
may be offered by each selling securityholder pursuant to this prospectus;
· the number of securities to
be beneficially owned by each selling securityholder following the sale of any securities covered by this prospectus; and
· the percentage of each
type of securities to be owned by each selling securityholder before and after the sale of the securities covered by this prospectus.
All information with respect to ownership of the selling securityholders’
shares has been furnished by or on behalf of the selling securityholders and, unless otherwise indicated, is as of June 23, 2023. Based
on information supplied by the selling securityholders, we believe that, except as may otherwise be indicated in the footnotes to the
table below, the selling securityholders have sole voting and dispositive power with respect to the securities reported as beneficially
owned by them.
Because the selling securityholders may sell,
transfer or otherwise dispose of all, some or none of the securities covered by this prospectus, we cannot determine the number of such
securities that will be sold, transferred or otherwise disposed of by the selling securityholders, or the amount or percentage of
securities that will be held by the selling securityholders upon termination of any particular offering or sale, if any. The selling securityholders
make no representations, however, that they will sell, transfer or otherwise dispose any securities in any particular offering or sale.
In addition, the selling securityholders may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose
of, at any time and from time to time, the ordinary shares they hold in transactions exempt from the registration requirements of the
Securities Act after the date on which they provided the information set forth on the table below. Solely for purposes of the requirements
applicable to the registration statement of which this prospectus forms a part, the following table assumes that the selling securityholders
will sell all of the securities owned beneficially by them that are covered by this prospectus, but will not sell any other securities
that they presently own.
Beneficial ownership is determined in accordance
with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership
of that person, we have included shares that the person has the right to acquire within 60 days, including through the exercise of any
option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of
the percentage ownership of any other person.
| |
Securities Beneficially Owned prior to this Offering | | |
Securities Being Registered for Resale | | |
Securities Beneficially Owned after this Offering | |
Name of Selling Securityholder | |
Ordinary Shares on an as converted basis | | |
| | |
Percentage (1) | | |
Ordinary Shares on an as converted basis | | |
| | |
Ordinary Shares on an as converted basis | | |
| | |
Percentage (1) | |
Qiangqiang Limited (2) | |
| 10,849,231 | | |
| | | |
| 4.75 | % | |
| 10,849,231 | | |
| | | |
| — | | |
| | | |
| — | |
Right Advance Management Limited (3) | |
| 6,046,054 | | |
| | | |
| 2.65 | % | |
| 6,046,054 | | |
| | | |
| — | | |
| | | |
| — | |
AutoB2B, LTD (4) | |
| 5,585,645 | | |
| | | |
| 2.45 | % | |
| 5,585,645 | | |
| | | |
| — | | |
| | | |
| — | |
HJDXL Limited (5) | |
| 5,374,270 | | |
| | | |
| 2.35 | % | |
| 5,374,270 | | |
| | | |
| — | | |
| | | |
| — | |
AADD Limited (6) | |
| 5,095,614 | | |
| | | |
| 2.23 | % | |
| 5,095,614 | | |
| | | |
| — | | |
| | | |
| — | |
Derong Group Limited (7) | |
| 4,406,542 | | |
| | | |
| 1.93 | % | |
| 4,406,542 | | |
| | | |
| — | | |
| | | |
| — | |
Dingqin Limited (8) | |
| 2,935,705 | | |
| | | |
| 1.29 | % | |
| 2,935,705 | | |
| | | |
| — | | |
| | | |
| — | |
Stanley Star Group Inc. (9) | |
| 50,000,000 | | |
| | | |
| 21.91 | % | |
| 50,000,000 | | |
| | | |
| — | | |
| | | |
| — | |
Yuan Liu (10) | |
| 2,800,000 | | |
| | | |
| 1.23 | % | |
| 2,800,000 | | |
| | | |
| — | | |
| | | |
| — | |
Xiaoqian Zha (10) | |
| 1,000,000 | | |
| | | |
| * | | |
| 1,000,000 | | |
| | | |
| — | | |
| | | |
| — | |
Jie Wu (10) | |
| 740,000 | | |
| | | |
| * | | |
| 740,000 | | |
| | | |
| — | | |
| | | |
| — | |
Guangqing Sun (10) | |
| 400,000 | | |
| | | |
| * | | |
| 400,000 | | |
| | | |
| — | | |
| | | |
| — | |
Lu Lin (10) | |
| 1,074,600 | | |
| | | |
| * | | |
| 1,074,600 | | |
| | | |
| — | | |
| | | |
| — | |
Donghong Zhang (10) | |
| 200,000 | | |
| | | |
| * | | |
| 200,000 | | |
| | | |
| — | | |
| | | |
| — | |
Jie Xu (10) | |
| 200,000 | | |
| | | |
| * | | |
| 200,000 | | |
| | | |
| — | | |
| | | |
| — | |
Tingting Wang (10) | |
| 200,000 | | |
| | | |
| * | | |
| 200,000 | | |
| | | |
| — | | |
| | | |
| — | |
Liang Hong (10) | |
| 100,000 | | |
| | | |
| * | | |
| 100,000 | | |
| | | |
| — | | |
| | | |
| — | |
* |
Less than 1% of our total outstanding ordinary shares. |
(1) |
Based on 228,250,210 ordinary shares of the Company issued as of December 31, 2022. |
|
|
(2) |
Represents 10,849,231 ordinary shares held by Qiangqiang Limited, a company incorporated in the British Virgin Islands and is controlled by Mr. Yun Wu. The registered address of Qiangqiang Limited is Start Chambers, Wickham’s Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands. |
|
|
(3) |
Represents 6,046,054 ordinary shares held by Right Advance Management Limited, a company incorporated in the British Virgin Islands and is controlled by Limei Wang. The registered address of Right Advance Management Limited is P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands. |
(4) |
Represents 5,585,645 ordinary shares held by AutoB2B, LTD, a company incorporated in the British Virgin Islands and is controlled by Ping Wang. The registered address of AutoB2B, LTD is 2/F, Palm Grove House, P.O. Box 3340, Road Town, Tortola, British Virgin Islands. |
(5) |
Represents 5,374,270 ordinary shares held by HJDXL Limited, a company incorporated in the British Virgin Islands and is controlled by Xiaolei Ding. The registered address of HJDXL Limited is Start Chambers, Wickham’s Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands. |
|
|
(6) |
Represents 5,095,614 ordinary shares held by AADD Limited, a company incorporated in the British Virgin Islands and is controlled by Da An. The registered address of AADD Limited is Start Chambers, Wickham’s Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands. |
(7) |
Represents 4,406,542 ordinary shares held by Derong Group Limited, a company incorporated in the British Virgin Islands and is controlled by Ting Li. The registered address of Derong Group Limited is Start Chambers, Wickham’s Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands. |
|
|
(8) |
Represents 2,935,705 ordinary shares held by Dingqin Limited, a company incorporated in the British Virgin Islands and is controlled by Shiqiong Hu. The registered address of Dingqin Limited is Start Chambers, Wickham’s Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Islands. |
|
|
(9) |
Represents 50,000,000 ordinary shares convertible from 50,000 Series F Convertible Preferred Shares of the Company held by Stanley Star Group Inc., a company incorporated in the British Virgin Islands and is controlled by Cai Xu. The registered address of Stanley Star Group Inc. is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. |
|
|
(10) |
The business address of these selling securityholders is c/o Kaixin Auto Holdings, 9/F, Tower A, Dongjin International Center, Huagong Road, Chaoyang District, Beijing 100015, People’s Republic of China. |
The selling securityholders and intermediaries
through whom such securities are sold may be deemed “underwriters” within the meaning of the Securities Act with respect to
the securities offered by this prospectus, and any profits realized or commissions received may be deemed underwriting compensation.
Additional selling securityholders not named in
this prospectus will not be able to use this prospectus for resales until they are named in the table above by prospectus supplement or
post-effective amendment. Transferees, successors and donees of identified selling securityholders will not be able to use this prospectus
for resales until they are named in the table above by prospectus supplement or post-effective amendment. If required, we will add transferees,
successors and donees by prospectus supplement in instances where the transferee, successor or donee has acquired its securities from
holders named in this prospectus after the effective date of this prospectus.
TAXATION
Material
income tax consequences relating to the purchase, ownership, and disposition of the securities offered by this prospectus are set forth
in “Item 10. Additional Information—E. Taxation” in our annual report on Form 20-F for the fiscal year ended December 31, 2022, which is incorporated herein by reference, as updated by our subsequent filings under the Exchange Act that are incorporated
by reference and, if applicable, in any accompanying prospectus supplement or relevant free writing prospectus.
EXPENSES
The following table sets forth the aggregate expenses
in connection with this offering, all of which will be paid by us. All amounts shown are estimates, except for the SEC registration fee.
SEC registration fee |
|
US$ |
27,985.59 |
|
Financial Industry Regulatory Authority fees |
|
US$ |
* |
|
Legal fees and expenses |
|
US$ |
* |
|
Accounting fees and expenses |
|
US$ |
* |
|
Printing and postage expenses |
|
US$ |
* |
|
Miscellaneous expenses |
|
US$ |
* |
|
Total |
|
US$ |
* |
|
* |
To be provided by a prospectus supplement or as an exhibit to a report of foreign private issuer on Form 6-K that is incorporated by reference into this registration statement. Estimated solely for this item. Actual expenses may vary. |
MATERIAL CONTRACTS
Our material contracts are described in the documents
incorporated by reference into this prospectus. See “Incorporation of Documents by Reference” below.
MATERIAL CHANGES
Except
as otherwise described in our annual report on Form 20-F for the fiscal year ended December 31, 2022, in our reports
of foreign private issuer on Form 6-K filed or submitted under the Exchange Act and incorporated by reference herein, and as disclosed
in this prospectus or the applicable prospectus supplement, no reportable material changes have occurred since December 31, 2022.
LEGAL MATTERS
We are being represented by King and Wood Mallesons
with respect to certain legal matters of U.S. federal securities and New York State law. The validity of the securities offered in this
offering and certain other legal matters as to Cayman Islands law will be passed upon for us by Maples and Calder (Hong Kong) LLP. Legal
matters as to PRC law will be passed upon for us by Dong Fang Law Offices. King and Wood Mallesons may rely upon Maples and Calder (Hong
Kong) LLP with respect to matters governed by Cayman Islands law and Dong Fang Law Offices with respect to matters governed by PRC law.
If legal matters in connection with offerings
made pursuant to this prospectus are passed upon by counsel to underwriters, dealers, or agents, such counsel will be named in the applicable
prospectus supplement relating to any such offering.
EXPERTS
The consolidated financial statements of Kaixin
Auto Holdings and its subsidiaries as of December 31, 2022 and for the year then ended incorporated in this prospectus by reference to
our annual
report on Form 20-F for the year ended December 31, 2022, have been so incorporated by reference in reliance on the report
of Onestop Assurance PAC, an independent registered public accounting firm, given the authority of said firm as experts in auditing and
accounting. Onestop is headquartered in Singapore.
The consolidated financial statements of Kaixin
Auto Holdings and its subsidiaries as of December 31, 2021 and for the years ended December 31, 2020 and 2021 incorporated in this prospectus
by reference to our annual
report on Form 20-F for the year ended December 31, 2022, have been so incorporated by reference in reliance on the report
of Marcum Asia CPAs LLP, an independent registered public accounting firm, given the authority of said firm as experts in auditing and
accounting. Marcum Asia CPAs LLP is headquartered in New York, New York.
INCORPORATION OF DOCUMENTS BY REFERENCE
The SEC allows us to “incorporate by reference”
into this prospectus certain information that we file with the SEC. This means that we can disclose important information to you by referring
you to those documents. Any statement contained in a document incorporated by reference in this prospectus shall be deemed to be modified
or superseded for purposes of this prospectus to the extent that a statement contained herein, or in any subsequently filed document,
which also is incorporated by reference herein, modifies or supersedes such earlier statement. Any such statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
We hereby incorporate by reference into this prospectus
the following documents:
(3) |
any future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering of the securities offered by this prospectus; and |
(4) |
any future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part. |
Our
annual report on Form 20-F for the fiscal year ended December 31, 2022 filed with the SEC on May 16, 2023 contains
a description of our business and audited consolidated financial statements with a report by our independent auditors. These statements
were prepared in accordance with U.S. GAAP.
Unless expressly incorporated by reference, nothing in this prospectus
shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC. Copies of all documents incorporated
by reference in this prospectus, other than exhibits to those documents unless such exhibits are specially incorporated by reference in
this prospectus, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this prospectus on
the written or oral request of that person made to:
KAIXIN AUTO HOLDINGS
9/F, Tower A, Dongjin International Center
Huagong Road
Chaoyang District, Beijing 100015
People’s Republic of China
+86 (10) 6720 4948
You should rely only on the information that
we incorporate by reference or provide in this prospectus. We have not authorized anyone to provide you with different information.
We are not making any offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not
assume that the information contained or incorporated in this prospectus by reference is accurate as of any date other than the date
of the document containing the information.
WHERE YOU CAN FIND ADDITIONAL INFORMATION
As permitted by SEC rules, this prospectus omits
certain information and exhibits that are included in the registration statement of which this prospectus forms a part. Since this prospectus
may not contain all of the information that you may find important, you should review the full text of these documents. If we have filed
a contract, agreement, or other document as an exhibit to the registration statement of which this prospectus forms a part, you should
read the exhibit for a more complete understanding of the document or matter involved. Each statement in this prospectus, including statements
incorporated by reference as discussed above, regarding a contract, agreement, or other document is qualified in its entirety by reference
to the actual document.
We are subject to periodic reporting and other
informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file reports,
including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be inspected over
the Internet at the SEC’s website at www.sec.gov. You can request copies of these documents, upon payment of a duplicating fee,
by writing to the SEC.
As a foreign private issuer, we are exempt under
the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our executive
officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16
of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic or current reports and financial statements
with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.
ENFORCEABILITY OF CIVIL LIABILITIES
We were incorporated in the Cayman Islands, as
an exempted company, in order to enjoy the following benefits:
|
● |
political and economic stability; |
|
● |
an effective judicial system; |
|
● |
a favorable tax system; |
|
● |
the absence of exchange control or currency restrictions; and |
|
● |
the availability of professional and support services. |
However, certain disadvantages accompany incorporation
in the Cayman Islands. These disadvantages include, but are not limited to, the following:
|
● |
the Cayman Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors as compared to the United States; and |
|
● |
Cayman Islands companies may not have standing to sue before the federal courts of the United States. |
Our constitutional documents do not contain provisions
requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors,
and shareholders, be arbitrated.
All of our operations are conducted outside the United States, and
all of our assets are located outside the United States. A majority of our directors and officers are nationals or residents of jurisdictions
other than the United States and a substantial portion of their assets are located outside the United States. Except for our chief financial
officer and director, Ms. Yi Yang, who is a U.S. citizen, all other officers and directors are PRC nationals. All of our officers
and directors reside within China, namely, our chairman and chief executive officer, Mr. Mingjun Lin, our chief financial officer
Ms. Yi Yang, and our directors Mr. Deqiang Chen, Mr. Xiaolei Gu, and Mr. Lin Cong. As a result, it may be difficult
for a shareholder to effect service of process within the United States upon these persons, or to enforce against us or them judgments
obtained in U.S. courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States
or any state in the United States.
We have appointed Cogency Global Inc. as our agent
upon whom process may be served in any action brought against us under the securities laws of the United States.
Maples and Calder (Hong Kong) LLP, our counsel
as to Cayman Islands law, has advised us that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us
or our directors or officers judgments of courts of the United States predicated upon the civil liability provisions of the securities
laws of the United States or any State; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against
us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any State,
so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement
in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign
money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a
competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain
conditions are met. For such a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for
a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of
the same matter, impeachable on the grounds of fraud or obtained in a manner, and or be of a kind the enforcement of which is, contrary
to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary
to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.
Dong Fang Law Offices, our counsel as to PRC law, has advised us that
there is uncertainty as to whether the courts of China, would:
|
● |
recognize or enforce judgments of U.S. courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States so far as the liabilities imposed by those provisions are penal in nature; or |
|
● |
entertain original actions brought in each respective jurisdiction against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States. |
We have been advised by our PRC legal counsel, that there is uncertainty
as to whether the courts of the PRC would enforce judgments of U.S. courts or Cayman courts obtained against us or these persons predicated
upon the civil liability provisions of the U.S. federal and state securities laws or Cayman Island laws. Dong Fang Law Offices has further
advised us that the recognition and enforcement of foreign judgments are provided for under PRC Civil Procedures Law. PRC courts may recognize
and enforce foreign judgments in accordance with the requirements of PRC Civil Procedures Law based either on treaties between China and
the country where the judgment is made or on reciprocity between jurisdictions. China does not have any treaties or other form of reciprocity
with the United States or the Cayman Islands that provide for the reciprocal recognition and enforcement of foreign judgments. In addition,
according to the PRC Civil Procedures Law, courts in the PRC will not enforce a foreign judgment against us or our directors and officers
if they decide that the judgment violates the basic principles of PRC law or national sovereignty, security or public interest. As a result,
it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States or in the Cayman
Islands.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 8. Indemnification of Directors and Officers
Cayman Islands law does not limit the extent to
which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the
extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime. Our Third Amended and Restated Memorandum and Articles of Association provides
that we shall indemnify our officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages, or liabilities
incurred or sustained by such directors or officer, other than by reason of such person’s own dishonesty, willful default, or fraud,
in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment) or in the execution
or discharge of his duties, powers, authorities, or discretions, including without prejudice to the generality of the foregoing, any costs,
expenses, losses, or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings
concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere.
In addition, we have entered into an indemnification
agreement with each of our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive
officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director
or officer of our company.
Item 9. Exhibits
See Exhibit Index beginning on page II-4
of this registration statement.
|
(a) |
The undersigned registrant hereby undertakes: |
|
(1) |
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
|
(i)
(ii) |
To include any prospectus required by Section 10(a)(3) of
the Securities Act of 1933;
To reflect in the prospectus any facts or events
arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee”
table in the effective registration statement. |
|
(iii) |
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
provided,
however, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) of this section do not apply if the information required
to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and
Exchange Commission by the registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated
by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b).
|
(2) |
That, for the purpose of determining any liability under the Securities Act of 1933, each such post- effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
|
(4) |
To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act of 1933 need not be furnished, provided, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act of 1933 or Rule 3-19 of Regulation S-K if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3. |
|
(5) |
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
|
(i) |
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
|
(ii) |
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
|
(6) |
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
|
(i) |
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
|
(ii) |
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
|
(iii) |
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
|
(iv) |
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
|
(b) |
That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
(c) |
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
INDEX TO EXHIBITS
Exhibit Number |
|
Description of Document |
|
|
|
1.1* |
|
Form of Placement Agency Agreement |
|
|
|
4.1
† |
|
Registrant’s
Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to our registration statement on Form S-1
(File No. 333-220510), as amended, initially filed with the SEC on October 18, 2017) |
|
|
|
4.2† |
|
Promissory
Note in the principal amount of $1,100,000 dated January 24, 2019 (incorporated by reference to Exhibit 10.6 to our annual
report on Form 10-K (File No. 001-38261) filed with the SEC on March 25, 2019) |
|
|
|
4.3† |
|
Promissory
Note in the principal amount of $1,013,629.30 dated January 24, 2019 (incorporated by reference to Exhibit 10.7 to our
annual report on Form 10-K (File No. 001-38261) filed with the SEC on March 25, 2019) |
|
|
|
4.4† |
|
Promissory
Note dated April 9, 2018 (incorporated by reference to Exhibit 10.1 to our current report on Form 8-K (File No. 001-38261)
filed with the SEC on April 13, 2018) |
|
|
|
4.5† |
|
Convertible
Promissory Note dated November 18, 2021 in the principle amount of $2,180,000 between Kaixin and Streeterville Capital, LLC
dated November 19, 2021 (incorporated by reference to Exhibit 4.40 to our current report on Form 20-F (File No. 001-38261)
filed with the SEC on May 16, 2023) |
|
|
|
4.6† |
|
Convertible
Promissory Note dated April 8, 2022 in the principle amount of $2,180,000 between Kaixin and Streeterville Capital, LLC dated
April 8, 2022 (incorporated by reference to Exhibit 4.42 to our current report on Form 20-F (File No. 001-38261)
filed with the SEC on May 16, 2023) |
|
|
|
4.7* |
|
Form of Preferred Shares |
|
|
|
4.8* |
|
Form of Debt Security |
|
|
|
4.9* |
|
Form of Warrant Agreement and Warrant Certificate |
|
|
|
4.10* |
|
Form of Unit Agreement and Unit Certificate |
|
|
|
5.1† |
|
Opinion
of Maples and Calder (Hong Kong) LLP (incorporated by reference to Exhibit 5.1 to the Form F-3 (File No. 333-272954) filed with the
SEC on June 27, 2023) |
|
|
|
23.1** |
|
Consent of Onestop Assurance PAC |
|
|
|
23.2** |
|
Consent of Marcum Asia CPAs LLP |
|
|
|
23.3† |
|
Consent
of Maples and Calder (Hong Kong) LLP (incorporated by reference to Exhibit 5.1 to the Form F-3 (File No. 333-272954) filed with the
SEC on June 27, 2023) |
|
|
|
24.1** |
|
Power of Attorney (included on signature page) |
|
|
|
107† |
|
Filing
Fee Table |
* |
|
To be filed, if applicable, by amendment or as an exhibit to a report filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and incorporated herein by reference. |
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Beijing,
People’s Republic of China, on August 11, 2023.
|
Kaixin Auto Holdings |
|
|
|
|
By: |
/s/ Yi Yang |
|
|
Name: Yi Yang |
|
|
Title: Chief Financial Officer |
|
|
(Principal Financial Officer) |
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons on August 11, 2023 in the capacities indicated.
Name |
|
Title |
|
|
|
/s/ Mingjun Lin |
|
Chief Executive Officer and Director |
Mingjun Lin |
|
(Principal Executive Officer) |
|
|
|
/s/ Yi Yang |
|
Chief Financial Officer and Director |
Yi Yang |
|
(Principal Financial Officer) |
|
|
|
/s/ Xiaolei Gu |
|
|
Xiaolei Gu |
|
Director |
|
|
|
|
|
|
/s/ Lin Cong |
|
|
Lin Cong |
|
Independent Director |
|
|
|
/s/ Deqiang Chen |
|
|
Deqiang Chen |
|
Independent Director |
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE
UNITED STATES
Pursuant to the Securities Act of 1933, as amended, the undersigned,
the duly authorized representative in the United States of America of Kaixin Auto Holdings, has signed this registration statement thereto
in New York, NY on August 11, 2023.
|
Cogency Global Inc. |
|
Authorized U.S. Representative |
|
|
|
|
By: |
/s/ Colleen A. De Vries |
|
Name: |
Colleen A. De Vries |
|
Title: |
Senior Vice President on behalf of Cogency Global Inc. |
Exhibit 23.1
![](https://www.sec.gov/Archives/edgar/data/1713539/000110465923090453/image_001.jpg) | |
Onestop Assurance PAC
10 Anson Road
#13-09 Interna�onal Plaza
Singapore 079903
Email: audit@onestop-ca.com
Website: www.onestop-ca.com |
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S
CONSENT
We consent to the incorporation by reference
in the Registration Statements on Amendment No. 1 to Form F-3 (333-272954) of Kaixin Auto Holdings of our report dated May 16,
2023, with respect to our audit of the consolidated financial statements of Kaixin Auto Holdings, which is included in this Annual Report
on Form 20- F for the year ended December 31, 2022.
/s/OneStop Assurance PAC
OneStop Assurance PAC
Singapore
August 11, 2023
Exhibit 23.2
Independent
Registered Public Accounting Firm’s Consent
We
consent to the incorporation by reference in this Registration Statement of Kaixin Auto Holdings on Amendment No.1 to Form F-3
(File No. 333-272954) of our report dated April 28, 2022, with respect to our audits of the consolidated financial statements
of Kaixin Auto Holdings as of December 31, 2021 and for each of the two years in the period ended December 31, 2021, appearing in the
Annual Report on Form 20-F of Kaixin Auto Holdings for the year ended December 31, 2021. We also consent to the reference to our Firm
under the heading "Experts" in the Prospectus, which is part of this Registration Statement.
/s/
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP
(Formerly Marcum Bernstein & Pinchuk LLP)
New York, NY
August 11, 2023
Kaixin (NASDAQ:KXIN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Kaixin (NASDAQ:KXIN)
Historical Stock Chart
From Aug 2023 to Aug 2024